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 EXECUTIVE SUMMARY 
 
In recent years, inventory reduction has been a key objective of pharmaceutical companies, 
especially within cost optimization initiatives. Pharmaceutical supply chains are characterized 
by volatile and unpredictable demands –especially in emergent markets-, high service levels, 
and complex, perishable finished-good portfolios, which makes keeping reasonable amounts of 
stock a true challenge. However, a one-way strategy towards zero-inventory is in reality 
inapplicable, due to the strategic nature and importance of the products being commercialised. 
Therefore, pharmaceutical supply chains are in need of new inventory strategies in order to 
remain competitive. 
Finished-goods inventory management in the pharmaceutical industry is closely related to the 
manufacturing systems and supply chain configurations that companies adopt. The factors 
considered in inventory management policies, however, do not always cover the full supply 
chain spectrum in which companies operate. This paper works under the pre-assumption that, 
in fact, there is a complex relationship between the inventory configurations that companies 
adopt and the factors behind them.  
The intention of this paper is to understand the factors driving high finished-goods inventory 
levels in pharmaceutical supply chains and assist supply chain managers in determining which 
of them can be influenced in order to reduce inventories to an optimal degree. Reasons for 
reducing inventory levels are found in high inventory holding and scrap related costs; in 
addition to lost sales for not being able to serve the customers with the adequate shelf life 
requirements. The thesis conducts a single case study research in a multi-national 
pharmaceutical company, which is used to examine typical inventory configurations and the 
factors affecting these configurations. 
This paper presents a framework that can assist supply chain managers in determining the most 
important inventory drivers in pharmaceutical supply chains. The findings in this study suggest 
that while external and downstream supply chain factors are recognized as being critical to 
pursue inventory optimization initiatives, pharmaceutical companies are oriented towards 
optimizing production processes and meeting regulatory requirements while still complying 
with high service levels, being internal factors the ones prevailing when making inventory 
management decisions. 
Furthermore, this paper investigates, through predictive modelling techniques, how various 
intrinsic and extrinsic factors influence the inventory configurations of the case study company. 
The study shows that inventory configurations are relatively unstable over time, especially in 
configurations that present high safety stock levels; and that production features and product 
characteristics are important explanatory factors behind high inventory levels. Regulatory 
requirements also play an important role in explaining the high strategic inventory levels that 
pharmaceutical companies hold. 
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Abstract 
Purpose –The aim of this paper is to present a novel framework which can assist pharmaceutical 
companies in identifying the factors driving inventory levels. Furthermore, the study provides 
practitioners with a methodology for assessing typical inventory configurations in pharmaceutical supply 
chains and the drivers behind them. Understanding these configurations and their relationship with 
intrinsic and extrinsic factors within the supply chain is fundamental in order to establish new inventory 
optimization strategies.  
Design/methodology/approach – The research is conducted using a single case study approach, which 
embeds a qualitative and a quantitative analysis. The qualitative analysis provides with an identification 
of the most influential inventory drivers in a pharmaceutical supply chain and assesses the positioning of 
the company with regards to the optimal inventory levels in a normalized scale. The quantitative analysis 
uses cluster analysis and predictive modelling techniques to investigate how various intrinsic and 
extrinsic factors influence the inventory configurations of the case study company. 
Findings – The findings in this study suggest that while external and downstream supply chain factors 
are recognized as being critical to pursue inventory reduction initiatives, pharmaceutical companies are 
usually oriented towards optimizing production processes and meeting regulatory requirements while 
still complying with high service levels; being internal factors the ones prevailing when making 
inventory management decisions. Furthermore, the study proves that the inventory configurations of the 
case study company are relatively unstable over time. Production features and product characteristics are 
important explanatory factors behind the company’s inventory levels.  
Practical implications – For practitioners, this paper reveals a framework which can assist practitioners 
in identifying the most important factors impacting inventory levels within a specific pharmaceutical 
supply chain configuration. 
Originality/value – Traditionally, inventory management research in the pharmaceutical industry has 
focused on studying the impact of quantitative factors on a company’s inventory levels. More abstract 
parameters such as managerial and cooperation factors are often ignored when assessing the company’s 
optimal inventory levels. Furthermore, the vast majority of existent literature does not address the 
particular inventory configurations that companies adopt within a single case study company.  
This paper contributes with novel insights by taking a more holistic approach to the subject in 
determining key inventory drivers and including a situation assessment of the case study company, 
proposing a theoretical framework which is useful for practitioners and relevant to the academia.  
Keywords: inventory management, stock, drivers, pharmaceutical supply chain, framework, statistical 
analysis, predictive modelling.  
  Article: Inventory Drivers in a Pharmaceutical Supply Chain                                                                                    Page 2 
 
As key strategic products, drugs and medicines’ supply is a top priority in any healthcare system 
(Kumar et al., 2009). Pharmaceutical supply chains will receive increasing attention in the 
upcoming years as their operational performance is yet far away from attaining full potential 
(Scheel et al., 2014). Furthermore, supply chain excellence can deliver a substantial competitive 
advantage and set companies apart from their rivals (Scheel et al., 2014). According to Booth 
(1999), “…there is a move away from viewing the supply chain as merely having to deliver security 
of supply at minimum cost to […] a recognition of its ability to generate value for both the customer 
and the shareholder”. 
The pharmaceutical sector has been undergoing major changes in the recent years. Internal and 
external forces are quickly reshaping the global environment in which the industry operates 
(Narayana et al., 2014). On the one hand, drug approval regulations are becoming stricter, and new 
drugs must provide significant health benefits over existing treatments to be approved (Shah, 2004). 
On the other hand, drugs are now more exposed to competition and substitute products such as 
generic drugs, due to the global marketplace being more liberalized (Shah, 2004).  
Pharmaceutical drugs and healthcare products have traditionally accounted for high prices leading 
to high profit margins. However, with medicine purchasers consolidating in key markets (Shah, 
2004; Peñafiel et al., 2014) and patents on drugs expiring in the upcoming years (PwC, 2011) 
pharmaceutical companies will now be forced to focus on cost savings more than ever (Winegarden, 
2014). As a result, pharmaceutical companies are revisiting their supply chains and identifying ways 
of extracting additional benefits from them (Shah, 2004). In this context, the cost of goods sold, its 
drivers and management are considered a major source of cost reduction potential (Scheel et al., 
2014).  
Pharmaceutical supply chains are characterized by high service levels, volatile and unpredictable 
demands –especially in emergent markets-, and complex, perishable finished-good portfolios 
(Uthayakumar and Priyan, 2013). The complex manufacturing processes and the (generally) low 
ratios of production sites to markets served increases supply chain complexity, making it a rather 
rigid network (Croxton and Zinn, 2005). These factors, combined with strict regulations imposed by 
governments and drug administrations, can make keeping reasonable inventory levels a daunting 
challenge (Scheel et al., 2014).  
The true challenge about inventory management in pharmaceutical companies is, on the one hand, 
that high profit margins lead, in consequence, to significant stock-out costs. In addition, there are 
reputational risks associated with not being able to serve the customers (Shah, 2004). On the other 
hand, overstocking is not desirable due to scrap and inventory carrying costs (Bragg, 2005).  
The costs associated to holding inventory can represent a high proportion of the total logistic costs 
(Holmgren and Wentz, 1982). Jarrett (1998) estimated that inventory investments in healthcare 
range between 10% and 18% of the total revenues, which is far more than in other industries 
(Jarrett, 1998).  In fact, total inventory in days on hand at the best-in-class consumer good firms 
accounts for 70% fewer days than at most pharmaceutical companies (Scheel et al., 2014). 
Therefore, it is crucial for supply chain managers to balance inventory levels in order to be able to 
serve the market while keeping costs as low as possible (Uthayakumar and Priyan, 2013). 
The topic of inventory management has been extensively investigated from diverse perspectives. 
Most of the research in this field includes the topics of demand planning, inventory control and 
inventory planning and scheduling (Beamon, 1998; Cachon and Zipkin, 1999; Axsäter, 2005; 
Chopra and Meindl, 2007). Other scholars have developed quantitative methods such as operations 
research, advanced mathematical models and simulation techniques that determine optimal 
inventory allocations based on a number of factors (Clark and Scarf, 1960; Barbosa-Povoa and 
Pantelides, 1999; Mak et al., 1999; Shah and Samsatli et al., 2000; Subramanian et al., 2001; 
Thonemann et al., 2002; Fischer, et al., 2004; Shah, 2004; Croxton and Zinn, 2005; Ballou, 2005; 
Axsäter, 2005; Johnsson and Mattson, 2009; Shapiro and Wagner, 2009; Kelle et al., 2012; 
Uthayakumar and Priyan, 2013; - this list is not exhaustive).  
1. Introduction 
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Extensive inventory management and inventory configurations research is performed in heavy 
manufacturing industries, such as the automobile or airplane manufacturing industries. However, 
only a small portion of this research has been undertaken on the problems faced by the 
pharmaceutical industry.  
One of the problems addressed in inventory literature in the pharmaceutical industry is the trade-off 
between holding inventory as a buffer against uncertainties and reducing scrap and inventory 
holding costs. Research on demand forecast in order to attain the desired service levels is also 
extensive in the field of pharmaceuticals and healthcare, with significant focus on reducing supply 
chain costs without sacrificing customer service (Uthayakumar and Priyan, 2013).  
Past literature has also often focused on optimizing inventory levels in pharmaceutical supply 
chains by constraining a (limited) set of drivers using mathematical models and simulations 
(Uthayakumar and Priyan, 2013; Kelle et al., 2012). Moreover, previous research into this area has 
developed models which often use simplifications of current supply chain designs (Arrow et al., 
1951; Clark and Scarf, 1960; Shah and Samsatli et al., 2000; Axsäter, 2005; Abhilasha and 
Prasanna, 2009; Uthayakumar and Priyan, 2013; Martinovic et al., 2016). Therefore, there is a lack 
of a more multidisciplinary approach in determining inventory configurations and the drivers 
behind inventory levels which can assist practitioners and their real suply chain settings.  
Narayana et al. (2014) adressed this issue by considering a more holistic view on inventory drivers. 
However, the focus of their research is on intra-organizational factors and does not provide an in-
depth investigation of external factors.  
Finally, another issue not addressed by literature is the existence of a systematic and objective 
methodology in quantifying the impact of inventory drivers within a single company.  
This paper combines two key areas that until now have been investigated separately in previous 
studies: finished-goods inventory management and inventory drivers, a key topic in academic 
research but that lacks of a more holistic and multidisciplinary approach; and inventory 
configurations in the pharmaceutical industry, which is especially relevant for practitioners. This 
paper extends the past research and contributes with a decision making framework that integrates a 
qualitative approach to determining inventory drivers and a quantitative analysis of the inventory 
configurations of a case company. 
Therefore, this paper seeks to answer the following questions (RQ): 
RQ1. What are the main drivers influencing inventory levels in multinational pharmaceutical 
supply chains and how can these drivers be categorized?  
RQ2. What are the main configurations of finished-goods inventory levels (i.e. Strategic 
Stock and Safety Stock) in a pharmaceutical supply chain?  Are these configurations stable over 
time? 
RQ2.a. How do the drivers identified impact different inventory configurations? 
The research questions have been addressed through an extensive literature review on inventory 
drivers in pharmaceutical supply chains and the case study of a case company, which has been 
named PharmaNordic for confidentiality reasons. PharmaNordic is currently developing processes 
to improve its inventory management in an international context. The scope of this study is limited 
to finished goods inventories held at the sales affiliates of the company. 
The remainder of the paper is structured as follows: Section 2 outlines the theoretical background in 
which the research is based and presents the identified inventory drivers. Section 3 introduces the 
Inventory Drivers Matrix framework, derived from the literature review. Section 4 presents the 
research methodology and research design.  Section 5 summarizes the key findings in the case study 
company, which are analysed using the framework in Section 6. Section 6 provides the answers to 
the research questions formulated in this study. Section 7 discusses the results and presents 
improvement suggestions. Section 8 highlights the implications for theory and practice and Section 
9 concludes with answers to the research questions and notes for further research.  
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This section outlines the theoretical foundations in which the research is based. First, the role of 
inventory within supply chain operations is discussed. Second, an exhaustive review on inventory 
drivers, their impact on inventory levels and existing classification categories is performed. A 
literature review summary table of specific inventory drivers for the pharmaceutical industry 
concludes the literature review. 
2.1. Inventory configurations: Cycle stock and Safety stock 
Inventories play a critical role in supply chains and is often a salient focus of supply chain managers 
(Esper and Waller, 2014) as they have a clear impact on the financial performance of a firm 
(Demeter and Golini, 2014). Its main function is that of facilitating the balance between demand  
and supply and to act as a buffer against uncertainties (Chopra and  Meindl, 2007).  
Inventory generally consists of safety stock and cycle stock (Lieberman and Helper et al., 1996; 
Axsäter, 2005; Chopra and  Meindl, 2007). Cycle stock is the portion of inventory that a company 
cycles through to satisfy regular sales orders (Chopra and  Meindl, 2007). Cycle inventory is also 
the mechanism that enables companies to exploit economies of scale and order in large lots; 
therefore lowering purchase costs (Chopra and  Meindl, 2007).  
Safety stock is a management tool for protecting the company against the uncertainty and variability 
of product demand and raw materials supply (Whybark and Williams, 1976). This instrument can 
simultaneously improve customer service and reduce the instability of production planning and 
scheduling (De Bodt and Wassenhove, 2001). Safety stock has also usually been referred as “buffer 
stock” or “strategic stock”. In addition, pipeline stocks are held while the product is being processed 
or transported (Lieberman and Helper et al., 1996). Since the focus of this research is on finished-
goods inventories held at distribution points (affiliates), pipeline stocks will be disregarded in the 
remainder of the study. 
Although the advantages of holding inventory are clear, the disadvantages have been increasingly 
recognised in literature (Apte and Viswanathan, 2000; Harrison and Van Hoek, 2005; Shields, 
2006; Chopra and  Meindl, 2007; Baker, 2007). High inventory levels negatively impact cash flow 
and warehousing capacity. Negative cost implications derived from storage and capacity fees, 
obsolete products reaching the end consumer and the adverse impact that this may have on supply 
chain responsiveness are just a few examples of the disadvantages of holding excess inventory. In 
addition, excess inventory can lead to drastic reductions in prices to encourage the purchase of 
inventory and thereby avoid high scrap rates (Shields, 2006).  
With increasing attention on inventory reduction strategies, a number of theories and methodologies 
have been developed with the aim of optimizing the amount of products that companies hold on 
stock. Some of the solutions applied to inventory management and control are: algebraic 
mathematical tools and techniques, dynamic programming and fuzzy/neural networks, heuristics, 
game theory, scenario/sensitivity analysis and simulation and descriptive statistics (Srivastava, 
2007). The latter constitutes the focal point of this study. 
2.2. Inventory drivers and categorization 
The first step to attempt reducing inventories is to understand what drives them. Past research has 
ventured to provide easy and understandable explanations of the link between inventory levels and 
its drivers. When looking across industries, there are a large number of factors which can impact 
inventory levels. 
Production and Internal Operation Capabilities have been widely discussed in literature as main 
inventory drivers. Parameters such as production volumes and production strategy, production 
capacity and capacity utilisation, lead time and lead time variability are relevant when identifying 
factors that impact inventory levels (Lieberman and Helper et al., 1996; Safizadeh and Ritzman, 
2. Literature review 
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1997; Wild, 2002; Ramakrishnan, 2006; Chopra and  Meindl, 2007;  Johnsson and Mattson, 2009; 
Ekstrand and Karlsfre, 2012; Hoppenheit and Günthner, 2015; Lam, 2017).  
Demeter and Matyusz (2011) ran an empirical study in which they demonstrated how different 
production strategies and processes impact inventory levels. Ekstrand and Karlsfre (2012) refer 
mainly to production features and internal logistic capabilities of the company (internal supply 
chain capabilities) as key parameters when establishing inventory level targets. 
Product Characteristics have also been recognized as key inventory drivers. Cachon and Olivares 
(2009) Hoppenheit and Günthner (2015) and Lea and Fredendall (2002) recognized product 
customization as a crucial factor in determining inventory levels. In this category, product 
complexity and perishability are also key areas explored by literature (Chopra and Meindl, 2007; 
Cachon and Olivares, 2009; Narayanapillai, 2014; Hoppenheit and Günthner, 2015). According to 
Lea and Fredendall (2002) product structure (or product complexity) is commonly measured by the 
differences in the breadth (i.e., number of immediate components per parent) and depth (i.e., the 
maximum number of levels) of the Bill-of-Materials (BOM) of a product. In their study, they 
demonstrate that highly complex products tend to be more stocked than simpler products, due to its 
high value for the company. 
The majority of scholars agree on finished-goods inventory levels being highly dependent on 
Market Factors such as demand, demand variability and forecast accuracy (Småros, et.al., 2003; 
Johnsson and Mattson, 2009; Ekstrand and Karlsfre, 2012; Hoppenheit and Günthner, 2015; Lam, 
2017). Although they appear in literature with less frequency, service level and distribution channel 
types are also included in this category (Johnsson and Mattson, 2009; Lam, 2017). 
Inventory levels also depend on Financial Drivers. Four very profilic authors in this field are 
Cachon and Zipkin (1999), Bragg (2005), Christopher (2005) and Chopra and Meindl (2007). The 
latter proposed two games that took into consideration order costs and holding costs and 
demonstrated that competitive supply chains see their total inventory cost increase, while 
cooperative supply chains are less cost-driven. Other costs considered by these authors are namely 
material, stok-out and scrap or obsolescence costs. The level of inventory tends to increase with the 
rise in the difference between price and marginal cost (Tashu, 2016).  
Upstream and Downstream Supply Chain (SC) Characteristics have been widely discussed in 
literature (Naylor et al., 1999; Wild, 2002, Olhager, 2003; Kang and Lee, 2010, Demeter and 
Matyusz, 2011; Demeter and Golini, 2014; Wikner and Johansson, 2015; Holwegl et al., 2015, -this 
list is not exhaustive). Upstream SC characteristics include drivers such as delivery performance 
and reliability from suppliers, delivery frequency, discounts from suppliers and lead time delivery 
form suppliers. Examples of relevant studies in this field are the research conducted by Kang and 
Lee (2010) and Hoppenheit and Günthner (2015). The latter paid special attention to upstream and 
downstream SC characteristics (what they call Source and Deliver factors) in a finished-goods 
inventory warehouse. Kang and Lee (2010) proposed a novel model for evaluating supplier 
performance and identified the supplier-driven parameters that have a direct effect on inventory: the 
ability of the suppliers to deliver on time, their warehousing capacity, responsiveness to change and 
the agreed service level, among others.  
Downstream SC characteristics drivers are mainly delivery lead time, delivery performance, 
transportation methods and decoupling point position in the supply. Long distances between 
suppliers and manufacturers or between manufacturers and customers leads to increasing inventory 
levels (Lieberman and Helper et al., 1996; Golini and Kalchschmidt, 2015). The latter used 
empirical studies to analyze the correlation between customer and supplier distance to 
manufacturers and inventory levels. In this category, the decoupling point has also been widely 
discussed as a main inventory driver (Naylor et al., 1999; Wild, 2002, Olhager, 2003; Demeter and 
Matyusz, 2011; Demeter and Golini, 2014; Wikner and Johansson, 2015).  
Demeter and Matyusz (2011) ran an empirical study on the correlation between inventory levels and 
decoupling points in the manufacturing industry.  
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Naylor et al. (1999) differentiated between 5 types of stock and their relationship with the 
decoupling point position within the supply chain, thus obtaining 5 different configurations: 
supplier stock, related to a buy-to-order policy, raw and semi-finished stock (make-to-order policy), 
WIP stock (assemble-to-order), finished goods stock (make-to-stock) and customers stock (ship-to-
stock).  Postponing the decoupling point in the supply chain increases agility and forecasting 
accuracy but also provides increased WIP inventory. 
Finally, there are a number of drivers which do not fall in any of the aforementioned categories and 
have therefore, been grouped under the name Miscellaneous. These parameters have received 
increasing attention in literature as they are usually harder to measure and quantify.  
Management’s commitment in reducion inventories, the degree of employee’s training and 
empowerment and personal biases are some of the inventory drivers mentioned in literature 
(Lieberman and Helper et al., 1996; Chen et al., 2005; Cachon and Olivares, 2009; Narayanapillai, 
2014; Holwegl et.al. 2015; Lam, 2017). Holwegl et al. (2015) mention supply chain collaboration 
and cooperation as essential factors in reducing inventory levels. Lieberman and Helper et al. 
(1996) compared information sharing methodologies such as Electronic Data Interchange (EDI) and 
Vendor Managed Inventory (VMI) across the US and Japanese automotive industry and their 
impact on finished goods inventory levels. 
When determining the impact on inventory levels, it is useful to classify the main drivers in 
different categories (Demeter and Golini, 2014). Inventory drivers’ classification methods have 
been developed by a number of scholars (Shepherd and Günter, 2006; Narayanapillai, 2014; 
Ziukov, 2015; Hoppenheit and Günthner, 2015; Lam, 2017).    
Shepherd and Günter (2006) described a systematic approach for supply chain performance 
measurement consisting on clustering key performance metrics according to the organizational level 
of the company the metrics belonged to: Strategic, Tactical and Operational measures. Lieberman 
and Helper et al., (1996) divided inventory drivers into Technological and Managerial factors. 
Narayanapillai (2014) built upon the former categories and added two new categories: contingency 
and organizational factors. Hoppenheit and Günthner (2015) used the SCOR model to classify 
inventory drivers into four categories: Source, Make, Deliver and Plan. Demeter and Golini (2013) 
opted for a similar approach and studied different types of inventory (input raw materials, WIP and 
output) and classified the factors impacting them into 4 groups: Market Factors, Internal Operations, 
Supply Chain characteristics and Business Strategy. Narrower classifications including strategy and 
organizational practices have been considered by Ekstrand and Karlsfre (2012), who developed a 
framework for parameter categorization which consisted on eight categories: Corporate Strategy, 
Organization, Economics, Forecast, Material Planning, Logistics, Supplier Influence and 
Production.  
While the possibilities for parameter classification are numerous, it is natural to think that the 
categorization used in each case study needs to be adapted to the industry and organizational 
structure in scope. The aforementioned groups do not cover the entire supply chain spectrum in 
which the present research is focused and therefore a tailored grouping is presented in Table 1. 
Table 1 summarizes the finished goods inventory drivers identified through a literature review 
across industries. For each factor, the table provides a brief definition on the factors, their 
classification into Quantitative (Q) or Qualitative (Qual.) parameters, their impact on cycle and 
safety stock (or cycle and safety stock if the particular inventory type is not specified) and which 
authors advocate for each of the drivers. In the next section, a review in relevant literature in the 
pharmaceutical industry is performed, and additional factors are appended to the table.  
Note that the factors are not prioritized among each other, and that some may be overlapping in 
terms of conceptualization. Furthermore, the factors presented might have different abstraction 
levels. Finally, the list presented does not differentiate if the parameters impact raw material or 
semi-finished inventories, in addition to their impact to finished-goods (FG) inventories. Although 
this differentiation might be implicit in some of the studies reviewed, it has not been taken into 
account as it would add an extra layer of complexity in the factors’ classification.  
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Order quantity or order 
size requirement 
(Q) 
*Some authors refer to 
it as Lot Size. 
The total number of stock-keeping-units (SKUs) that 
customers place on a single order.  
 
Cycle stock 
↑  OQ →  Inventory 
levels ↑ 
Order quantities determine production batch sizes, where the 
batch size is determined based on economical quantities for the 
processes. Changeover costs are also associated with batch 
sizes. Higher order quantities lead to higher batch sizes and 
higher inventory levels; while production flexibility decreases.  
(Ekstrand and Karlsfre, 2012) (Hoppenheit and 
Günthner, 2015)  (Johnsson and Mattson, 2009) 
(Lam, 2017)  (Lieberman et al., 1996) 
(Ramakrishnan, 2006) (Safizadeh and Ritzman, 
1997) (Wild T. , 2002) (Chopra and Meindl, 2007) 
Order/replenishment 
policy  
(Qual.) 
A set of procedures for determining when to order and 
with what quantity as a function of the level of tied up 
capital in material flow, delivery service and 
utilization of resources.  
Safety stock 
- Continuous review →  
Inventory levels ↓ 
-Periodic review → 
Inventory levels ↑(for 
the same LT and SL). 
In the continuous review process, inventory levels are 
continuously reviewed, and as soon as the stocks fall below the 
Reorder Point, a replenishment order is placed. Under periodic 
review, inventory status is checked at regular periodic intervals 
and an order is placed to raise the inventory level to a specific 
threshold. 
(Ekstrand and Karlsfre, 2012)  (Hoppenheit and 
Günthner, 2015)  (Johnsson and Mattson, 2009) 
(Ramakrishnan, 2006) (Chopra and Meindl, 2007) 
Production capacity 
utilization 
(Q) 
Extent to which the productive capacity of a plant (or 
production line) is being used in generation of 
products. Expressed usually as a percentage, it is 
computed by dividing the total capacity with the 
portion being utilized.  
Cycle + Safety stock 
↑ Capacity utilization 
→ Inventory levels ↑↓ 
(ambiguous) 
Limited production capacity will reduce the ability of the 
company to produce if needed when a peak of demand occurs. 
This leads to produce in advance and stock the excess of 
production for that time period. On the other hand, excess of 
capacity can lead to produce more than the necessary amount in 
order to achieve economies of scale. 
(Lam, 2017) (Narayanapillai, 2014) 
(Ramakrishnan, 2006)  
Production flexibility 
(Qual.) 
 
 
Machine flexibility (the ability to create different 
product types or change the order in which the 
processes are operated) + Routing flexibility (ability 
of more than one machine to perform the same 
process or adjust for changes in capacity or volume). 
Cycle + Safety stock 
↑ Flexibility → 
Inventory levels ↓ 
Production ﬂexibility allows a ﬁrm to track production more 
closely to sales, thereby yielding a lower optimal level of safety 
stock for a ﬁrm.  
(Demeter and Golini, 2014) (Gerwin, 1993) 
(Newman et al., 1993) 
(Cachon and Olivares, 2009) 
Lead time  
(Q) 
The amount of time that elapses between when an 
order is placed at a production site and until it is 
released form production, including the potential 
delays due to stock outs at upper echelons. 
Safety stock 
↑ Lead times → 
Inventory levels ↑ 
The effect is accentuated in global supply chains, where 
suppliers and customers are located far away from each other. 
The ratio of production sites to markets served also increases 
lead time and hence, inventory levels. 
(Ekstrand and Karlsfre, 2012)   (Golini and 
Kalchschmidt, 2015) (Hoppenheit and Günthner, 
2015) (Lam, 2017) (Narayanapillai, 2014) 
(Ramakrishnan, 2006) (Chopra and Meindl, 2007) 
Lead time variance  
(Q) 
Measured as Standard Deviation of Lead Time: σLT. Safety stock 
↑  LT uncertainty →  
Inventory levels ↑ 
 
Lead Time uncertainty tends to increase safety stock levels, 
which act as a buffer against these supply uncertainties. 
(Ekstrand and Karlsfre, 2012) (Golini and 
Kalchschmidt, 2015) (Hoppenheit and Günthner, 
2015) (Johnsson and Mattson, 2009) (Bandalay et 
al., 2016) (Chopra and Meindl, 2007) 
Production Strategy 
(Qual.) 
There are four commonly production strategies 
accepted in scientific literature: Make-to-Stock 
(MTS), Make-to-Order (MTO), Assemble-to-Stock 
(ATS) and Assemble-to-Order (ATO). 
Cycle + Safety stock 
MTS →  Inventory 
levels ↑ 
MTO →  Inventory ↓ 
MTO companies tend to have higher input inventories and MTS 
companies have higher FG inventories. Companies pursuing 
ATO strategies have lower input inventory levels but not higher 
WIP inventory. Mass production increases FG inventory. 
(Demeter and Golini, 2014) (Ekstrand and 
Karlsfre, 2012)    (Hoppenheit and Günthner, 
2015)  (Johnsson and Mattson, 2009) 
Inventory Space  
(Q) 
Square meters dedicated to store, handle and manage 
inventories. 
Cycle + Safety stock 
↑  Inventory space →  
Inventory levels ↑ 
 (Hoppenheit and Günthner, 2015) (Narayanapillai, 
2014) 
P
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Product customization 
/specialization(Qual.) 
Number of product variants shared across markets vs. 
market specific products. 
Safety stock 
↑  Specialization →  
Inventory levels ↑ 
Wider product range causes higher inventory levels due to 
higher production switching times to serve the needs of various 
markets. Furthermore, it is harder to predict demand for a larger 
product portfolio than for a limited portfolio. 
(Cachon and Olivares, 2009) (Hoppenheit and 
Günthner, 2015) (Demeter and Golini, 2014) (Lea 
& Fredendall, 2002) (Narayanapillai, 2014) 
(Chopra and Meindl, 2007) 
Product complexity 
(Qual.) 
The number of materials used to produce a product, or 
number of prime materials. Usually measured 
according to the number of materials in the bill of 
materials (BOM). 
Safety stock 
↑  Prime materials →  
Inventory levels  
 
*However, Lieberman et.al. (1996) found that there is not a 
discernible relationship between product complexity and 
inventory levels. 
(Ekstrand and Karlsfre, 2012) (Hoppenheit and 
Günthner, 2015) (Lieberman et al., 1996)  (Lea 
and Fredendall, 2002) (Chopra and Meindl, 2007)   
(Kang and Lee, 2010) 
Shelf life/product 
durability (Q) 
 
Length of time that a commodity may be stored 
without becoming unfit for use, consumption, or sale. 
Cycle + Safety stock 
↑  Shelf life →  
Inventory levels ↑ 
Perishable products will tend to spend less time on stock, given 
that companies try to sell them as quick as possible so that 
products arrive to the customer with high remaining shelf life. 
(Ekstrand and Karlsfre, 2012) (Johnsson and 
Mattson, 2009) (Ramakrishnan, 2006) (Shah, 
2004) 
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Average demand per 
product (Q) 
The systematic component of demand, predicted by 
the forecast. Measured in number of units per period 
of time. 
Cycle stock 
↑  Demand →  
Inventory levels↑ 
Besides the demand level, most authors focus on demand 
distribution (or demand pattern) as an important parameter for 
inventory control.   
(Ekstrand and Karlsfre, 2012)   (Johnsson and 
Mattson, 2009) (Lam, 2017) (Ramakrishnan, 
2006) (Chopra and Meindl, 2007) 
Standard deviation of 
demand, or demand 
variability (Q) 
The random component of demand, usually estimated 
by the demand forecast: σD. 
Safety stock 
↑  Standard deviation of 
demand →  Inventory 
levels ↑ 
 (Ekstrand and Karlsfre, 2012)   (Lee et al., 2000) 
(Ramakrishnan, 2006) (Narayanapillai, 2014) 
(Chopra and Meindl, 2007)  (Shah, 2004) 
Forecast accuracy (Q) The goal of forecasting is to predict the systematic 
demand and estimate the random component of 
demand. 
Safety stock 
↑  Forecast accuracy →  
Inventory levels ↓ 
A poor forecast will lead to high inventory levels in prevention 
for being able to meet the required service levels, ultimately 
leading to high scrap rates and inventory holding costs. The 
bullwhip effect is caused due to the effects of demand 
forecasting and can be reduced by centralizing demand 
information through VMI systems. 
(Ekstrand and Karlsfre, 2012)    (Hoppenheit and 
Günthner, 2015) (Johnsson and Mattson, 2009) 
(Lam, 2017) (Småros, et.al., 2003) 
Forecast 
horizon/demand 
forecasting frequency 
(Q) 
Frequency in which the sales or demand forecast is 
updated. 
*Note: the terms sales and demand are used 
interchangeably.  
Safety stock 
↑  Forecast Horizons →  
Inventory levels↑ 
Forecasts increase in uncertainty the longer the time horizon of 
the forecast is; and thereby also inventory levels increase. 
(Ekstrand and Karlsfre, 2012)   (Johnsson and 
Mattson, 2009) (Narayanapillai, 2014) (Lysons 
and Farrington, 2012) 
Service Level (Q) 
 
The customer service level is the indicator of the 
amount of customer demand satisfied from available 
inventory. It is measured by means of the cycle 
service level or the fill rate. 
Safety stock 
↑  CSL →  Inventory 
levels ↑ 
High service levels enable high customer service and hence, 
high revenues. However, high service levels require of high 
levels of inventories in an exponential relation. 
(Cachon & Olivares, 2009) (Ekstrand and Karlsfre, 
2012)   (Lam, 2017) (Johnsson and Mattson, 2009) 
(Chopra & Meindl, 2007) (Shah, 2004) 
Sales channel type and 
type of contract  
The way products are commercialised and sold to 
customers: Tender offers, rebates, etc. 
Tender offers →  
Inventory levels ↑ 
Tender agreement contracts usually tend to increase safety stock 
levels due to strategic reasons. 
(Hoppenheit and Günthner, 2015) 
F
in
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l 
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Material cost (Q) Cost of raw materials and components. Cycle stock 
↓  Material cost →  
Inventory levels ↑ 
High material costs (relative to other costs like overhead or 
work costs) leads to lower inventory levels, as companies try to 
reduce financial associated risks. 
(Beamon, 1998) (Bragg, 2005)  (Christopher, 
2005) (Cachon and Olivares, 2009) (Demeter and 
Golini, 2014) (Chopra and Meindl, 2007) 
Product price/unit (Q) Price at which products are sold to customers. Cycle stock 
↑ Product price →  
Inventory levels ↓ 
There is a negative correlation between product price and the 
levels of finished goods, WIP and raw materials inventory. The 
more expensive the final product is, the lower the inventory. 
This is especially significant in WIP inventories, and is 
consistent with the EOQ model. 
(Bragg, 2005)  (Cachon and Zipkin, 1999)  
(Cachon and Olivares, 2009) (Demeter and Golini, 
2014) (Lieberman et al., 1996) (Ramakrishnan, 
2006) (Chopra and Meindl, 2007) 
Order cost (Q) Order cost includes all incremental costs associated 
with placing or receiving an order that are incurred 
regardless of the size of the order. 
Cycle stock 
↓  Order cost →  
Inventory levels ↑ 
Companies will try to reduce order costs by placing bigger 
orders (higher order quantities) and therefore, increasing 
inventory levels.  
(Bragg, 2005) (Cachon and Zipkin, 1999) (Lam, 
2017) (Chopra and Meindl, 2007) (Christopher, 
2005) 
Holding cost (Q) The cost of keeping one product in stock for one time 
unit.  
Cycle stock 
↓  Holding cost →  
Inventory levels ↑ 
Holding cost is estimated as a percentage of the cost of a 
product and contains the following components: Cost of capital, 
handling costs, occupancy costs and miscellaneous. 
(Bragg, 2005) (Cachon and Zipkin, 1999)  (Lam, 
2017) (Narayanapillai, 2014) (Chopra and Meindl, 
2007)  (Christopher, 2005) 
Stock-out penalty cost 
(Q) 
Stock-out is the cost associated with the lost 
opportunity caused by the exhaustion of the inventory, 
or cost per product unit and time unit of not having a 
product in stock when it is demanded.  
Cycle + Safety stock 
↑Stock-out penalty cost 
→  Inventory levels ↑ 
There is an inverse relationship between stock-out penalty costs 
and inventory levels. The higher the penalty cost, the more 
efforts companies put into ensuring a minimum safety stock, 
which leads to higher inventories. 
(Ramakrishnan, 2006)  (Chopra and Meindl, 2007) 
(Christopher, 2005) 
Scrap or obsolescence 
Costs (Q) 
Obsolescence costs estimate the rate at which the 
value of the stored product drops because its market 
value or quality falls. 
Cycle + Safety stock 
↑  Scrap costs →  
Inventory levels ↓ 
Perishable products have high obsolescence rates. Even non-
perishable products can have high obsolescence rates if they 
have short life cycles. 
(Bragg, 2005) (Ekstrand and Karlsfre, 2012)    
(Christopher, 2005) (Ramakrishnan, 2006)  
(Chopra & Meindl, 2007)  
Transportation cost per 
product (Q) 
A fix transportation cost that is incurred regardless of 
the size of the order and variable cost associated to the 
volumes being transported. 
Cycle + Safety stock  
↑  Transportation costs 
→  Inventory levels ↑ 
Transportation costs are related to a number of other factors, 
such as item cost and volume, component variation, lead time 
and inventory interest rates.  
(Ekstrand and Karlsfre, 2012) (Chopra and 
Meindl, 2007) (Christopher, 2005) 
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Delivery performance 
and reliability (Qual.) 
Refers to the extent to which companies trust their 
supplier in terms of on-time delivery, avoiding supply 
stock-outs, etc. 
Safety stock 
↑ Supplier reliability→  
Inventory levels↓ 
WIP and FG inventory levels are low when supplier’s reliability 
is high. Closer and trustful relationships with suppliers allow 
companies to reduce safety stock. 
(Ekstrand and Karlsfre, 2012) (Hoppenheit and 
Günthner, 2015) (Lam, 2017) (Demeter and 
Golini, 2014)  (Kang and Lee, 2010) 
Delivery frequency 
from suppliers(Q) 
The frequency by which suppliers deliver raw 
materials, semi-finished products and packaging 
materials to the company. 
Cycle stock 
↑Delivery frequency →  
Inventory levels↓ 
(ambiguous) 
A low delivery frequency leads companies to order higher lot 
sizes. Higher supplier lot sizes lead to higher inventory levels 
(raw materials and WIP). On the contrary, Lieberman et al. 
(1996) found that there is not a significant correlation between 
delivery lot sizes and the level of finished goods inventory.   
(Hoppenheit & Günthner, 2015) (Lieberman et al., 
1996) (Lieberman and Helper, 1996)  (Kang and 
Lee, 2010)  (Chopra and Meindl, 2007) 
Discounts from 
Suppliers (Qual.) 
Quantity discounts are valuable in a supply chain for 
(i) Improved coordination to increase total SC profits 
and (ii) Extraction of surplus through price 
discrimination. 
Cycle stock 
↑Discounts →  
Inventory levels↑ 
Lot-size based quantity discounts increase the lot size and cycle 
inventory within the supply chain because they encourage 
buyers to purchase in larger quantities to take advantage of the 
decrease in price.  
(Lam, 2017)  (Kang and Lee, 2010) (Chopra and 
Meindl, 2007) 
Lead time delivery 
from suppliers (Q) 
Lead time is the amount of time that elapses between 
when an order is placed from the buyers and until it is 
received. 
Safety stock 
↑  LT from suppliers →  
Inventory levels ↑ 
 
Inventories usually increase if the Lead Time delivery from the 
suppliers increases. 
*It is usually is referred in conjunction with production lead 
time and lead time to customers 
 (Golini et.al, 2015) (Lam, 2017) (Ramakrishnan, 
2006)  (Kang and Lee, 2010) (Chopra and Meindl, 
2007) 
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Lead time delivery to 
customers (Q) 
Lead time is the amount of time that elapses between 
when an order is released from a production site until 
it is received by the customers. 
Safety stock 
↑  LT from suppliers →  
Inventory levels ↑ 
 
Long distances between suppliers and customers 
lead to an increase in inventories in order to guarantee flexibility 
and variability, especially in global supply chains. 
(Golini and Kalchschmidt, 2015) (Lam, 2017) 
(Ramakrishnan, 2006) 
Decoupling point 
position (Qual.) 
 
The customer order decoupling point (CODP) 
identifies the point in the material flow where the 
product is linked to a specific customer. 
Postponement is the ability of a SC to delay product 
differentiation or customization until closer to the 
time a product is sold. 
Safety + Cycle stock 
Postponing the de-
coupling point:→  
finished goods 
inventory ↓ 
Postponing → WIP 
level ↑ 
The most commonly accepted classifications and their relation 
to inventory buffers are:  Supplier stock, related to a buy-to-
order policy, raw and semi-finished stock (make-to-order 
policy), WIP stock (assemble- to-order), finished goods stock 
(make-to-stock) and customers stock (ship-to-stock).   
Postponing the decoupling point increases agility and 
forecasting accuracy but increased WIP and FG inventory. 
(Demeter and Golini, 2014) (Demeter and 
Matyusz, 2011) (Naylor et al., 1999)  (Olhager, 
2003)  (Wikner and Johansson, 2015) (Wild T. , 
2002) 
Type of transportation 
(Qual.) 
 
 
 
 
In FTL (full-track-loads), components for one 
customer fill up one truck, while Less than truckload 
shipping (LTL) is the transportation of relatively 
small freight per each truck. 
Cycle + Safety stock 
↑  FTL→  Inventory 
levels ↑ 
LTL →  Inventory 
levels  ↓ 
 
With full truckload (TL), shipments typically travel on only one 
truck with one destination, so delivery time estimates are often 
accurate and fast in comparison to less than truckload (LTL) 
shipping. From transportation cost of view, there might be 
economies of scale achievable by despatching in larger 
quantities (e.g. FTL) and this would tend to increase cycle stock. 
(Ekstrand and Karlsfre, 2012) 
(Baker, 2007) 
M
is
ce
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Outsourced logistics 
(Qual.) 
Logistics outsourcing involves a relationship between 
a company and a logistic service provider (LSP), 
which has customized offerings, is long-term oriented 
and encompasses a broad number of service activities. 
Cycle + Safety stock 
↑  Outsourcing logistic 
activities →  Inventory 
levels ↑ 
When companies outsource their (or a part of) logistic 
operations to external companies, they lose visibility and control 
of the product. This can lead to higher inventory levels in form 
of safety stock.  
(Ekstrand and Karlsfre, 2012) (Hoppenheit and 
Günthner, 2015) 
Lean supply chain 
capabilities 
(Qual.) 
The degree to which the company implements Lean 
principles in its inventory management and control 
activities. 
Cycle + Safety stock 
↑ Lean → Inventory 
levels ↑ 
Following lean principles, companies can reduce the level of 
different types of inventories. WIP inventory reduction has 
occurred in many industries as a result of the implementation of 
lean practices and a flexible production setup. 
(Demeter and Golini, 2014) (Lieberman et al., 
1996) (Lieberman and Deemester, 1999) (Cachon 
and Olivares, 2009) (Chen et al., 2005)   
Personal bias 
(Qual.) 
The actions of planners and other stakeholders in 
contradicting the directions of the planning systems 
and other automatic tools. 
Cycle + Safety stock 
↑ Bias → Inventory 
levels ↑ 
Given the complexity of inventory management, planners and 
other SC players tend to apply practical solutions, which are not 
always optimal. 
(Lam, 2017) 
Management attitude 
towards inventory 
control (Qual.) 
Management’s focus on reducing inventory levels. Cycle + Safety stock 
↑ Management attitude 
to reduce inventory → 
Inventory levels ↓ 
Empirical studies have shown that management’s attitude 
towards inventory control has a direct impact on inventory 
levels. Industries with a stock-optimization focus, (e.g. the 
automotive industry) present lower inventory levels that 
companies with much less focus on inventory control. 
(Ekstrand and Karlsfre, 2012) (Golini and 
Kalchschmidt, 2015)  (Lieberman et al., 1996)  
(Narayanapillai, 2014)  
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Degree of employees 
training and 
empowerment (Qual.) 
Employee’s training level and autonomy to develop 
initiatives to reduce inventory levels. 
Cycle + Safety stock 
↑ Autonomy and 
initiatives → Inventory 
levels ↓ 
Whether the employees at a manufacturing site have completed 
formalized training or not has an impact on inventory levels. 
Inventory levels decrease when workers are expected to make 
substantial improvements in their own method of operations and 
receive proper training. 
(Lieberman et al., 1996) (Narayanapillai, 2014) 
Information sharing 
and centralisation 
(Qual.) 
Degree of information sharing across supply chain 
players and centralisation of this information for 
planning purposes. Vendor Managed  Inventory 
(VMI) and computer-based  information technology 
systems facilitate coordination among SC players. 
Cycle + Safety stock 
↑ Information sharing 
→ Inventory levels ↓ 
Information sharing reduces inventory and inventory costs and 
increases service levels, as it helps coordinating upstream 
schedules with downstream production, thereby reducing the 
need for intermediate (WIP) and finished-goods inventories. 
Vertical integrated SC are more efficient in managing 
inventories.  
(Demeter and Golini, 2014) (Cachon and Fisher, 
2000)  (Lee et.al., 2000) (Lieberman et al., 1996) 
(Shah and Shin, 2007)  (Montoya-Torres and 
Ortiz-Vargas, 2014) 
Degree of cooperation 
among SC players 
(Qual.) 
Can be measured as Degree of coordination among 
SC players. 
Cycle + Safety stock 
Lack of coordination 
among SC players → 
Inventory levels ↑ 
The supply chain profit is lower if each stage of the supply chain 
makes its pricing, order size and lead time decisions 
independently, with the objective of maximizing only its own 
profit. Cooperation activities also reflect on inventory levels 
held at different stages of the supply chain. 
(Cachon and Zipkin, 1999) (Holwegl et.al., 2015) 
(Chopra and Meindl, 2007) (Shah and Shin, 2007) 
Degree of 
centralization / de-
centralization (Qual.) 
The degree of inventory centralisation in fewer 
stocking points. 
Safety stock 
↑ Degree of 
Centralisation → 
Inventory levels ↓ 
Aggregating (or centralising) is recommended to decrease the 
amount of safety stock. Aggregating inventories, can, on the 
other hand, lead to an increase in response time to customer 
order and an increase in transportation costs. 
(Chopra and Meindl, 2007) 
 Regulatory constraints 
(Qual.) 
The degree to which supply chains are designed to 
meet regulatory constraints from medical agencies 
and governments. 
Safety Stock 
↑ Regulatory constraints 
(stricter) → Inventory 
levels ↑ 
 (Shah, 2004) (Uthayakumar and Priyan, 2013) 
      
Table 1. Summary of factors impacting finished-goods inventory levels and classification 
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2.3. Inventory research in the pharmaceutical industry 
The relationship between inventory drivers and inventory levels has been extensively studied in the 
automotive or assembly industries (Lieberman and Asaba, 1997; Beamon, 1998; Cachon and 
Zipkin, 1999; Axsäter, 2005; Hoppenheit and Günthner, 2015). Lieberman and Asaba (1997) 
pointed the main differences regarding inventory performance across the supply chains of Japanese 
and U.S. automobile manufacturers. Lieberman and Deemester (1999) studied the impact of 
inventory reduction on productivity in 57 japanese automotive companies and found a correlation 
between JIT practices and the factors impacting inventory levels. Hoppenheit and Günthner (2015) 
reported the impact of more than 43 parameters on inventory levels in a commercial vehicle 
company with the aim of identifying the root-causes for high raw materials, WIP and finished goods 
inventory levels. 
The pharmaceutial industry, however, has driven much less research in this field. Only a small 
proportion of  the work done within inventory and distribution planning directly addresses the 
issues faced in the pharmaceutical sector. A number of researchers have compared inventory 
performance across pharmaceutical companies (Shah, 2004; Kelle et al., 2012; Narayana, et al., 
2014). However, there are few studies that identify the parameters impacting inventory levels in a 
specific pharmaceutical company (Uthayakumar and Priyan, 2013). Another limitation faced by 
research in the industry is that they often focus on optimizing inventory levels by constraining a 
(limited) set of drivers, while other important drivers might be omitted: Uthayakumar and Priyan 
(2013) and  Kelle et al., (2012) focus on near-optimal allocation policies in pharmaceutical supply 
chains under space constraints but do not consider demand variability, forecast accuracy or 
regulatory constraints. Shah (2004) adresses this by considering a more holistic view on inventory 
drivers. However, the focus of her research is on intra-organizational parameters and does not 
consider external factors. 
The majority of the studies related to pharmaceutical supply chains outlined the same parameters 
covered by the exploratory literature review. However, the refined literature review revealed four 
factors which are considered especially relevant in pharmaceutical supply chains: demand volatility, 
product shelf life, regulatory constraints and service level (Shah, 2004; Uthayakumar and Priyan, 
2013, Scheel et.al, 2014). The first three drivers are already outlined in Table 1. The driver 
regulatory constraints was added to the table, as it was not identified before.  
Table 2 provides a summary of inventory drivers in the pharmaceutical industry. The column 
Cycle/Safety stock Impact refers to the inventory configuration each driver has more impact on: 
Cycle (C) or Safety (S) stock. When the impact is evenly distributed in safety and cycle stock, or 
the impact is ambiguous, the sign C+S has been used.  
The literature review proposes that all the factors listed influence the levels of inventory in a 
pharmaceutical supply chain. In the next sections, a new factor framework is developed. The 
framework is applied to a case study company, in which  the impact of the different factors on 
inventory levels is assessed in a particular supply chain structure.This serves to  test the proposed 
inventory drivers and enhance the practicality of the developed  framework as a decision support 
tool.  
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Table 2. Summary of inventory drivers in the pharmaceutical industry and references used 
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Based on the literature review performed, a new factor framework was developed. The need for 
creating a new framework arises from the different perspectives in which numerous authors define 
and categorize the inventory drivers previously identified. The framework developed provides an 
exhaustive overview on the main categories of factors affecting inventory levels and the respective 
sub-factors that should be considered in defining inventory optimization initiatives. 
3.1.   A framework for inventory drivers’ classification 
Critical to any academic research study that seeks to test theories about phenomena and build upon 
them is a firm foundation based on relevant definitions (Wacker, 2004). The same principle can be 
applied to classification frameworks. Inventory classification frameworks have been developed by a 
number of scholars, as discussed in Section 2. However, these classifications usually comprehend a 
broader definition of the problem (namely, they consider raw materials, semi-finished and finished-
goods inventories) and cannot be exactly replicated to this specific case study.  
Therefore, a tailored classification framework was developed to build a common ground in which to 
sustain the subsequent analysis, benefitting the case study firm and facilitating future research in 
this topic in the pharmaceutical industry. 
The seven categories depicted in Figure 1, are identified as the factor categories influencing 
finished-goods inventory levels. The framework builds upon the work of Hoppenheit and Günthner 
(2015) and Ekstrand and Karlsfre (2012). The latter present one of the most comprehensive 
categorization among the reviewed publications.  
The main contribution besides identifying and adding single sub-factors to each category, is the 
formulation of a seventh category –Cooperation and other Managerial Factors, which groups the 
factors considered under Miscellaneous in Table 1. In other to differentiate the work done, the new 
framework has been named “Inventory Drivers Matrix”(IDM) framework. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3. A new classification framework 
Upstream Supply Chain Downstream Supply Chain 
Internal 
Operation 
Capabilities 
Market Factors
Financial 
Factors
Upstream 
Supply Chain 
Characteristics
Downstream 
Sypply Chain 
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Characteristics
Inventory 
Levels 
Production/Internal 
Operation Capabilities 
Product Characteristics Market Factors 
Downstream SC Characteristics Upstream SC Characteristics 
Cooperation and Managerial Factors 
Financial Factors 
Figure 1. The Inventory Drivers Matrix (IDM) framework: main classification categories 
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3.2. Refining the framework 
The seven categories of inventory drivers cover the entire supply chain spectrum in which the 
company operates. This is an important distinction from the inventory management problem as 
appointed by the vast amount of literature, which usually focuses on a few (intrinsic) factors. 
Therefore, the framework presented was refined in order to incorporate a new dimension: External 
and Internal factors. Figure 2 shows the refined framework and incorporates specific factors for 
each category. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The framework is bi-dimensional: it divides the different factors according to their relative 
positioning in the supply chain (Upstream or Downstream Supply Chain factors) and at the same 
time considers whether these factors are extrinsic (inherently driven by external forces) or intrinsic 
(can be affected and/or modified by the company). Within each category, the areas shadowed in 
grey (higher position in the Y-axis) highlight the factors that have been considered intrinsic to the 
company. The factors highlighted with a star (*) are of especial importance in the pharmaceutical 
industry, according to literature. It should be noted, however, that very few of these parameters are 
exclusive to this industry.  
The categories of the IDM framework can be described as follows: 
1. Production/Internal Operation Capabilities: This category contains the drivers related to 
the manufacturing of the final product, production strategy and characteristics of the 
company: production strategy, replenishment policies, production flexibility, order quantity 
and order size, capacity utilization, production lead time and lead-time variance and space 
reserved for inventory. 
2. Product characteristics: The category refers to special qualities of the product being 
manufactured: Product customization –to a specific market-, product complexity and shelf 
life requirements. 
3. Market Factors: This category contains drivers related -or close to- the end customer of 
the product and the predictability of the customer’s behaviour: forecast accuracy and time 
horizon (forecast frequency), service level commitment, sales channel type and type of 
purchase contracts, average demand and standard deviation of demand (demand volatility). 
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1. Production/Internal Operation Capabilities 
Order Quantity or Order Size  
Order/Replenishment Policy  
Production Capacity Utilization  
Production Flexibility  
Production Lead Time  
Production Lead Time Variance  
Production Strategy  
Inventory Space 
2. Product Characteristics 
Product Customization  
Product Complexity  
* Shelf Life (Product Durability) 
3. Market Factors  
Forecast Accuracy  
Forecast Horizon/Frequency  
* Service Level  
Sales Channel Type and Contract  
Average Demand per product  
* Standard deviation of Demand 
6. Downstream SC Characteristics 
Lead Time Delivery to Customers 
Decoupling point position 
Type of Transportation 
5. Upstream SC Characteristics  
Lead Time Delivery from Suppliers 
Discounts from Suppliers  
Delivery Performance and Reliability 
Delivery Frequency from suppliers 
7. Cooperation and Managerial Factors 
Lean Supply Chain Capabilities  
Personal Bias  
Management Attitude towards Inventory Control  
Degree of Employee training & empowerment  
Degree of centralization 
Information Sharing and Centralization  
Degree of Cooperation among SC players  
Outsourced Logistics  
* Regulations Requirements 
4. Financial Factors  
Material Cost | Holding Cost | Scrap or Obsolescence Cost | * Stock-out penalty Cost | Transportation Cost | Order Cost | Product price 
Figure 2. Inventory Drivers Matrix framework (IDM framework) 
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These factors are strongly related to customers’ behaviour (i.e. close to downstream SC 
nodes) and have, therefore, been placed in the right side of the matrix. 
4. Financial Factors: This category contains mainly the costs related to holding an SKU on 
stock and the value of the product stored. Sub-factors in this category are costs of material, 
holding, scrap, stock-out penalties, transportation and order costs and the final price per unit 
of the product stored. The factors are allocated from left to right: from supplier proximity 
(material cost) to customer proximity (product price).  
5. Upstream SC characteristics: This category entails the drivers related to the availability 
of the raw materials and activities that take place at the upstream node of the supply chain, 
hereafter, the sourcing of raw materials and supplier’s performance: degree of supplier 
orientation of the company, lead time delivery from suppliers, discounts from suppliers, 
delivery performance and reliability, delivery frequency from suppliers. 
6. Downstream SC characteristics: This category is concerned with the proximity to the end 
customer and contains the following drivers: degree of customer orientation, lead time 
delivery to customers, decoupling point position and type of transportation. The factors are 
close to the upstream supply chain nodes and have, therefore, been placed in the right side 
of the matrix. 
7. Cooperation and other Managerial related Factors: This category is concerned with 
intra-organizational factors such as the availability of organizational structures and systems 
that facilitate managing inventory levels as well as factors related to governmental and 
agencies regulations on the product and its inventory management. Sub-factors in this 
category are lean supply chain capabilities, personal bias, management attitude towards 
inventory control, degree of employee training & empowerment, information sharing and 
centralization, aggregation (centralization/de-centralization), degree of cooperation among 
SC players, outsourced logistics and regulation requirements. 
 
The framework presented does not intend to find an optimal allocation of inventories in a given 
company, but rather to make supply chain managers reflect on contextual parameters that can affect 
inventory levels. It also provides the ground rules to be considered when determining the 
company’s optimal inventory levels. The framework’s validity, reliability and usefulness of 
application to the case study company are discussed in the methodology. 
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The methodology adopted in this research is based on a case study approach. A case study is an 
empirical analysis that investigates contemporary phenomenon within its real-life context (Yin, 
1989). The aim of a case study has been defined by Hartley (2004) as being “to provide an analysis 
of the context and processes which illuminate the theoretical issues being studied". 
Case study research is deemed especially robust as a research method when the study requires of a 
holistic, in-depth investigation (Zainal, 2007), which is the case of the present study. A case study 
approach is appropriate when the questions ''how'' or "why" are being posed in a context where the 
researcher has little control over a set of contemporary phenomenon (Yin, 2003). 
Unlike quantitative studies which observe patterns in data using large samples, case studies observe 
data of a small sample at a micro-level (Zainal, 2007). In the present study, the sample is composed 
of a unique case company. The rationale for choosing a single case study over a multiple-case study 
approach is the objective of capturing critical circumstances of a generalized situation (Yin, 2003). 
The fact that no other cases are available for replication underpins the selection of a single case 
study. Yin (2003) names this rationale as Representative or Typical case. Despite a few 
particularities, it has been deemed that the case company selected for the study represents similar 
players in the industry.  
While single case studies can contribute significantly to knowledge and theory building (Yin, 2003), 
they present three main disadvantages. The first one is their inability to generalize the findings of 
the research, in contrast to quantitative methods (Voss et al., 2002; Hartley, 2004; Zainal, 2007). 
Second, it has been claimed that they lack robustness in collecting data and validating results 
(Kohlbacher, 2006). Finally, case studies are criticized for being difficult to conduct, due to the 
massive amount of documentation they generate. The case analysis will be further triangulated with 
other methods in order to overcome this critique, as suggested by Zainal (2007).  
Within the three main case study categories defined by Yin (1984), the descriptive case study has 
been used for the present research. Descriptive case studies are appropriate when the aim is to study 
particular aspects of a topic (Zainal, 2007) when there is already a theoretical model (Yin, 1994). 
Within the descriptive case study, the deductive method has been chosen over the inductive. The 
deductive method provides a higher level of reliability when the findings are based on a single case 
company (Hilmola et al., 2005).  
The nature of the research questions has prompted to use a mix of quantitative and qualitative 
methods which have supported the attainment of the objectives in this study: assess the case 
company’s current inventory levels and determine suggestions for reducing them. The goal of the 
case study, as outlined by Wacker (1998) is two-fold: to validate, refine and sequentially improve 
the theoretical framework, which is presented in Section 4, and to provide insights into practical 
implications of the framework’s implementation. 
4.1. Case study company 
The case company is a multi-national pharmaceutical company headquartered in Denmark. 
Dedicated to the manufacturing, marketing and distributing of pharmaceutical products, the 
company, which has been named PharmaNordic for confidentiality reasons, markets its products in 
more than 180 countries. PharmaNordic has several lines of businesses. However, only diabetes 
products have been considered in this study, given that the rest of products are more complex, their 
supply chain is less mature and their production follows an on-demand strategy. Diabetes-related 
drugs are the core business of the company.  
PharmaNordic is currently developing processes to improve its inventory management in an 
international context by analysing inventory configurations in their affiliates; goal that corresponds 
to the research questions presented in this study. The case study company will help validating and 
refining the proposed theoretical model, which corresponds to the theory building concept outlined 
by Voss et al.(2002). 
4. Research methodology 
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4.2. Literature review 
The aim the literature review in this study is two-fold: to develop an in-depth understanding of the 
contextual parameters impacting inventory levels in the pharmaceutical industry and to explore 
prior work related to inventory configurations and inventory management from a statistical 
(quantitative) perspective. There are two main phases in the literature review, namely exploratory 
and refined literature review. The process, which has a broader focus at the beginning and becomes 
narrower as the research progresses, is based on the model developed by Liston (2006), as detailed 
in Figure 3.  
 
Figure 3. Literature review methodology 
The exploratory literature review consists of steps 1 and 2: initial and exploratory literature review. 
The initial literature review has the objective of selecting the adequate scope for the research, 
exploring previous research done in the field and selecting the research question/s. The outcome is, 
in turn, used as an input for the exploratory literature review process (step 2). The aim of this 
second step is to narrow down the search, focusing on the topics of inventory drivers, classification 
methodologies and statistical analysis as means of inventory control. The refined literature review 
consists of steps 3 and 4, and focuses on past research on inventory management in the 
pharmaceutical industry. The search for relevant articles related to inventory drivers in the 
pharmaceutical industry was performed following the guidelines developed by Liston (2006) and 
was extended using the citation pearl growing strategy. The literature search was made on journal 
articles, reports, websites, conference papers, consultancy white papers and course books. 
Table 3 summarizes the key terms used in the exploratory and refined steps of the literature review, 
the preliminary articles selected for an abstract review and the total number of articles read. 
Table 3. Keywords and searched terms: exploratory and refined literature review 
Exploratory literature review Refined literature review 
Primary key words Secondary key words Primary Key words Secondary key words 
Supply Chain 
Inventory, Management, Statistics, 
Control 
Inventory control 
Pharmaceutical, pharma, 
healthcare, drug  
Inventory, Stock Control, Management, Parameters Inventory, Stock 
Control, Management, 
Parameters, Policy 
Multi-echelon, 
Inventory 
Optimization, Simulation, Control, 
Approach, Policy 
Pharmaceutical 
company 
Statistics, multiple 
regression, Decision Tree 
Exclusion criteria 
Content not relevant to identification and 
classification of inventory drivers 
Exclusion criteria 
Content not referring to the 
pharmaceutical industry 
Articles selected 83 Articles selected 36 
Articles read 23 Articles read 28 
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The main search engines employed were DTUfindit, the Danmarks Tekniske Universitet library 
database, the Google Scholar web search engine and GLIA, the company’s internal database for 
specific topics related to the business.  
4.3. Data collection and method of analysis 
The purpose of the analysis performed is two-fold, and depends on the research questions 
formulated in this study. Figure 4 depicts the qualitative and quantitative analyses performed and 
the methodologies used in each of the sub-steps of the analyses.  
The first research question (RQ1) is answered by means of a qualitative analysis. The goal is to 
determine the importance of each of the factors presented in the theoretical framework and assess 
the company’s current and optimal stock positioning in a normalized scale.  
First, the IDM framework is applied to the case study company using a survey questionnaire. The 
scores that each factor receives determine the importance score and identify the most important 
factors driving inventory levels as perceived by the survey respondents. Second, the impact score of 
each factor is determined by combining the theoretical concepts outlined in the literature review and 
an assessment of each factor’s direction in the case study company (i.e. 1 if pointing towards 
increasing inventory levels, 0 if ambiguous and -1 if pointing towards decreasing inventory levels).  
In particular, a double assessment is made: the AS-IS and the TO-BE situation assessment. Both 
assessment streams are performed simultaneously and are the result of an exhaustive examination of 
literature and condensation of the information extracted through the interviews conducted.  
The combination of the importance and impact score across all factors as detailed in formula (1) 
determines the positioning of the company with regards to its inventory levels in comparison to the 
maximum overstock levels in two scenarios: the current situation (AS-IS) and the attainable optimal 
situation (TO-BE). The potential impact score considers an overstocking situation, as if all factors 
point towards increasing inventory levels (1). 
(1) 𝑆𝑡𝑜𝑐𝑘𝑖𝑛𝑔 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛𝑖𝑛𝑔 =
∑ (𝐼𝑚𝑝𝑜𝑟𝑡𝑎𝑛𝑐𝑒 𝑠𝑐𝑜𝑟𝑒𝑖∙𝐼𝑚𝑝𝑎𝑐𝑡 𝑠𝑐𝑜𝑟𝑒𝑖)𝑖
∑ (𝑖 𝐼𝑚𝑝𝑜𝑟𝑡𝑎𝑛𝑐𝑒 𝑠𝑐𝑜𝑟𝑒𝑖∙𝑃𝑜𝑡𝑒𝑛𝑡𝑖𝑎𝑙 𝑖𝑚𝑝𝑎𝑐𝑡 𝑠𝑐𝑜𝑟𝑒𝑖)
∙ 100 
The expression includes normalization, so the results range between 0% and 100%. 
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Figure 4. Overview of the analyses performed and methodologies employed. 
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The objective of the quantitative analysis is to answer the second research question (RQ2). The 
methodologies used in the quantitative analysis use a combination of descriptive statistics, 
clustering algorithms and predictive models, as outlined in Figure 4. The accuracy of the study 
depends heavily on the appropriateness of the methodologies employed. Therefore, the most 
adequate methodology has been chosen to perform each part of the quantitative analysis. 
To pursue the research goals, data from the case study company was collected from three main 
sources: (i) interviews conducted among employees holding positions within the case study 
company with relevant insights for the research, (ii) surveys and (iii) data extractions from the 
company’s Enterprise Resource Planning (ERP) systems. The data collected is both qualitative and 
quantitative.  
The remainder of this section contains a detailed explanation of the data collected, the 
methodologies used to analyse the data and the outcome of each methodology. 
4.3.1. Methodologies employed in the qualitative analysis (RQ1) 
Survey questionnaire design 
The aim of conducting a survey study in the case company is to identify the main drivers 
influencing inventory levels, with the ultimate goal of determining an importance score for each of 
the factors in the IDM framework. A secondary objective is to identify which factors present 
improvement opportunities (focus areas) from an inventory management perspective in the case 
company. 
The process followed to develop the survey is the following. First, a list of hypotheses was drawn to 
include all possible information which could be tested among the targeted population subject to 
study. The hypotheses were constructed through the combination of a literature review screening 
and an analysis of internal documentation of the case study company. Second, the hypothesis were 
transformed into questions, which were divided into five sections depending on the topic covered. 
The number of initial questions was 86. An exhaustive elimination process was then performed in 
order to reduce the number of questions and focus on issues related to the research questions. The 
total number of questions was reduced to 53.  
The distribution of questions among the different sections of the survey is shown in Table 4.  
Table 4. Distribution of questions among sections in the survey study 
Survey Section No. of questions 
Distribution 
percentage 
1. Practical Information 3 6% 
2. Identifying the main issues within inventory 
management in the case study company 
2 (Multiple 
statements) 
11% 
3. Specific issue: overstocking and stock-outs 7 13% 
4. Factors impacting inventory levels (rating) 35 62% 
5. Final remarks 6 7% 
Total 53 100% 
Sections 2 and 3 of the survey were designed to identify the main issues faced by the company with 
regards to inventory management. Section 4 aimed to rate the importance of each factor in driving 
inventory levels and used a five-point Likert scale with 1 being “Not important” and 5 “Extremely 
important”. The initial hypotheses formulated, complete survey questionnaire and rationale for each 
question can be seen in Appendix A-Survey Questionnaire.  
The system used to conduct the survey was Google Forms, which was chosen among three other 
alternatives for the following reasons: 
- Google Forms provides an easy to use interface for the respondents. 
- It reduces complexity and time for the researcher when creating the survey. 
- It allows for exporting the data from the answers to an excel file, enabling further analysis of 
the answers and extrapolation of findings. 
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Sampling approach 
The sample targeted in this research consisted of supply chain specialists, managers and supply 
chain planners with at least one year of experience in their current role. The reason for this selection 
is that employees with less experience might lack the necessary business acumen to answer the 
survey questionnaire. For practical reasons, it was not possible to survey an entire population, and 
therefore a sample of the population was deemed more suitable for study (Brewerton and Millward, 
2001).  
Furthermore, an exploratory approach within a descriptive case study -the one underpinning this 
research- does not require of a large population sample, since the objective of the research seeks 
greater depth than breath (Isaac and Michael, 1995).  
Therefore, a sampling frame was developed to target specific individuals with the necessary 
knowledge to provide valuable insights to the research. Table 5 depicts the total population sample 
amongst which the respondents were selected and the criteria employed to select survey 
respondents. The final total sample size was 16 and the response rate was 43.2%. 
Table 5. Population sample of the survey questionnaire 
Criteria for respondent selection Group size 
 Potential respondents (employees within the S&OP and SNP planning, 
Production Planning, Supply Chain Design and Analytics 
departments). 
102 
 The respondent must have had a role in which inventory 
management decisions are made. 
87 
 The respondent has spent at least one year in its current role 
within the case study company. 
38 
 Target survey study sample 38 
Number of respondents to the survey and response rate 16 (43.2%) 
Figure 5 depicts the number of respondents categorized by their role in the case study company and 
the degree to which they have a complete overview on inventory management processes. 
 
 
 
Figure 5. Number of respondents to the survey per role (left) and degree to which they have a complete overview on 
inventory management processes (right).  
For simplification purposes, the respondents were further categorized into two groups: (i) Supply 
Chain Planners (S&OP, SNP and production) and (ii) Supply Chain Specialists and Managers. 
Survey analysis 
In order to investigate the relative importance of the factors rated in the survey questionnaire, 
descriptive statistics procedures were employed. Mean and standard deviation measures are invalid 
descriptive statistics measures when data is presented in ordinal scales (Allen and Seaman, 2015). 
Therefore, non-parametric procedures based on the median and interquartile ranges of the answers 
were employed for that purpose. The median was chosen over the mean as a measure of central 
tendency, given that this measure is less susceptible to the influence of outliers (Allen and Seaman, 
2015). The fact that some of the factors being rated in the survey clearly showed a skewed 
distribution of the scores underpinned the selection of the median as a measure of central tendency. 
In particular, Kruskal-Wallis tests were performed for each category of the framework to test the 
importance of each inventory driver within a category.  
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The Kruskal-Wallis test, which avoids issues related to the non-normal distributions of the data,  
identified if there was any factor (group) within a category that had a statistically significant score 
compared to the other factors (Kruskal, 1952) working under the following hypothesis: 
(𝑛𝑢𝑙𝑙) 𝐻0: ?̃?𝐹𝑎𝑐𝑡𝑜𝑟1 = ?̃?𝐹𝑎𝑐𝑡𝑜𝑟2 = ?̃?𝐹𝑎𝑐𝑡𝑜𝑟3 = ⋯ = ?̃?𝐹𝑎𝑐𝑡𝑜𝑟𝑛  (All medians within a category are statistically equal) 
            𝐻1: 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒                                                       (At least one median is higher than the others within the category) 
The p-value significance was set at 5% (p-values lower than a 5% indicate rejection of the null 
hypothesis).  
The second set of descriptive statistics consisted on a set of boxplots containing the medians of the 
scores received by each factor in the framework. The medians determined the importance score (see 
Figure 4). 
Finally, the relative weight of the categories comprised in the IDM framework was computed by 
dividing the average rating of the factors within a specific category between the average score 
across all factors, according to formula (1): 
(1)    𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑐𝑎𝑡𝑒𝑔𝑜𝑟𝑦 𝑖𝑚𝑝𝑜𝑟𝑡𝑎𝑛𝑐𝑒𝑐𝑎𝑡𝑒𝑔𝑜𝑟𝑦 𝑖 =
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑟𝑎𝑡𝑖𝑛𝑔 𝑜𝑓 𝑓𝑎𝑐𝑡𝑜𝑟𝑠𝑐𝑎𝑡𝑒𝑔𝑜𝑟𝑦 𝑖
∑ 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑟𝑎𝑡𝑖𝑛𝑔 𝑜𝑓 𝑓𝑎𝑐𝑡𝑜𝑟𝑠𝑖  𝑎𝑐𝑟𝑜𝑠𝑠 𝑐𝑎𝑡𝑒𝑔𝑜𝑟𝑖𝑒𝑠
∙ 100 
Semi-structured interviews 
Several interviews were conducted among employees holding different positions in the case study 
company. In single case studies, interviews are an efficient way of gaining knowledge about the 
case company which is not documented (Kvale, 1996), given its depth an explorative nature. The 
interview method selected was a semi-structured interview approach, since it allows for exploration 
of specific themes and ideas and gives the interviewees the necessary freedom to express their 
concerns and opinions about the topic being covered (Bharmani, 2005).  
The interviewed subjects were selected by examining the survey results and identifying respondents 
which represented outliers (namely, their answers differentiated from the average response). The 
interviews were conducted following a pre-prepared interview guide. The guide was not always 
followed rigidly, allowing the interviewee to make free associations with related topics.  
The aim of the interviews conducted is summarized in four main phases of collecting data: 
(i) Preliminary phase: Gain a general understanding of the company’s products and supply 
chain operations. This provided the qualitative background information for the study 
research. The preliminary interviews were also used to clarify doubts on the ERP systems’ 
structure. 
(ii) Assessment phase: Facilitating the assessment of the impact score of each of the factors in 
the theoretical framework.  
(iii) Improvement phase: Identify the main focus areas (i.e. factors which present shortcomings 
with regards to inventory management and could help reduce the company’s inventory 
levels). 
(iv) Evaluation phase: Evaluate the framework’s validity and usefulness for the case study 
company. 
The assessment and improvement phases were conducted in parallel in the interviews. In order to 
assess the impact score of the factors in the framework, the qualitative data collected was 
transformed into empirical data using the four steps defined by Malterud (2012): looking at the 
interview in full, assigning themes to each specific section of the interview, coding the themes and 
assigning an empirical value to each factor covered. The information obtained in the interviews, 
combined with the theoretical background gained through the literature review, facilitated assigning 
an impact score to each factor of the framework: 1 if the factor pointed towards high inventory 
levels, 0 if the factor was ambiguous and -1 if the factor pointed towards reducing inventories. 
Tape recording and note taking were used as a method for documenting the interviews, with the 
previous consent of the interviewees.  
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Table 6 provides a detailed overview on the interviewed stakeholders and the topics covered.  
Table 6.Overview of the interviews conducted in the case study company 
# Interviewee Date and 
duration 
Phase Topic Format 
1 Supply 
Chain 
Specialists 
06/02/2017 
125 min 
Preliminary Introduction to the company’s operations, 
supply chain configuration and overall 
governance structure in inventory 
management. 
Unstructured 
interview. Notes 
(no transcription). 
2 Supply 
Chain 
Consultant 
22/02/2017 
60 min 
Preliminary Introduction to affiliates’ configuration: MRP 
and non-MRP countries.  
Unstructured 
interview. Notes 
(no transcription). 
3 Supply 
Chain 
Specialist  
24/02/2017 
45 min 
Preliminary Discussion on the selected parameters for the 
quantitative analysis. Introduction to the case 
study company’s ERP systems.   
Unstructured 
interview. Notes 
(no transcription). 
4 Data 
Scientist  
01/03/2017 
120 min 
Preliminary Discussion on the mapping of the variables 
selected for the quantitative analysis with the 
SQL tables in the internal database. 
Unstructured 
interview. Notes 
(no transcription). 
5 Supply 
Chain 
Director 
24/03/2017 
60 min 
Assessment 
+ 
Improvement 
Inventory management strategy and policies. 
Introduction to the Inventory Management 
model. Issues related to the IM model. 
Semi-structured 
interview. Notes 
(no transcription). 
6 Production 
planner (OP) 
04/05/2017 
Site visit 
Assessment 
+ 
Improvement 
Assessment of the factors in the framework. 
Replenishment policies. Focus on product 
characteristics 
Semi-structured 
interview. Notes 
(no transcription). 
7 Production 
planner (OP) 
at production 
site 
17/05/2017 
Site visit  
(6h) 
Assessment 
+ 
Improvement 
Assessment of the factors in the framework. 
Replenishment policies. Focus on production 
processes: Production capacity under-
utilization and push vs. pull strategy. 
Semi-structured 
interview (Audio 
file + transcript) 
8 Senior 
Business 
Analyst  
22/05/2017 
30 min 
Assessment 
+ 
Improvement 
Assessment of the factors in the framework. 
Focus on demand volatility, forecast accuracy 
and exploring key issues within inventory 
management (personal bias and info. 
sharing). 
Semi-structured 
interview (Audio 
file + transcript) 
9 Senior Raw 
Materials 
Controller  
23/05/2017 
30 min 
Assessment 
+ 
Improvement 
Assessment of factors in the framework. 
Identification of issues related to 
transportation methods, centralization/de-
centralization strategies and service levels. 
Semi-structured 
interview (Audio 
file + transcript) 
1
0 
Senior 
S&OP 
Planner 
02/06/2017 
60 min 
Assessment 
+ 
Improvement 
Assessment of factors in the framework. 
Identification of issues related to production 
lead times and delivery lead times. 3PLs role 
in the current supply chain configuration. 
Semi-structured 
interview (Audio 
file + transcript) 
1
1 
Group 
session 
07/06/2017 
90 min 
Evaluation Feedback session for validating the 
theoretical framework (IDM). 
Unstructured  
Refer to Appendix B-Interview guide and transcripts for the transcripts of interviews 7-10. 
4.3.2. Methodologies employed in the quantitative analysis (RQ2) 
To pursue the second research goal (RQ2), a quantitative analysis based on data from the case study 
company’s ERP systems was performed.  
In this study, a dataset comprising weekly inventory data for several products was first clustered 
into four groups and then subject to predictive modelling methods: Multiple Linear Regression 
Analysis (MLR) and Decision Tree (DT) models. The cluster analysis was performed in order to 
explore the existing inventory configurations in the case study company and their evolution in time. 
The predictive modelling techniques evaluated the importance of different factors in determining 
inventory levels in each cluster. The mathematical and statistical computations were made using 
Alteryx® (v10.6) and R (i386 v3.3.1). 
The iterative process depicted in Figure 6 was followed as a systematic approach to conduct the 
quantitative analysis. The first four steps are common for all the analysis performed. Steps 3 and 
four are re-iterative. Step 5 differs depending on the techniques employed (clustering and predictive 
modelling). Step 6 is discussed under the validity section. 
10 
11 
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4.3.2.1. Data collection and preparation 
The dataset in which the analysis was based was constructed by combining different SQL tables 
(entities) extracted from the company’s ERP systems, as shown in Appendix C-Data preparation.  
The dataset consisted on weekly inventory data for 13 different finished-goods insulin products 
recorded at 46 different sales affiliates. The time frame comprised was from week 1 in January 2015 
until week 21 in 2017 (referred as 2017 year-to-date, YTD).  
 
 
 
 
 
 
 
 
 
 
 
4.3.2.2. Data exploration, cleansing and filtering  
In order to prepare the data for the data analysis, the data was explored and missing data analyzed. 
Furthermore, the data was explored for basic descriptive statistics and correlations. A total of 2093 
observations were detected as outliers and removed from the sample. The final dataset (once the 
data was cleansed and filtered) contained 56.975 records (observations).  
Each record had a number of variables associated to it. In particular, a total of 19 variables were 
associated to each inventory record. The variables contained information on stock metrics (strategic, 
safety and total stock, if the material number is stock-out or over the maximum stock level target), 
production-related factors (lead time and production plant), product characteristics (e.g. name of the 
product and packaging size) and market-related factors (e.g. historic demand for the past 26 weeks, 
converted into daily demand).  
The variables were divided into three variable types: numeric, categorical and date formatted 
variables.  Numerical variables contain values that describe a measurable quantity as a number 
(Anderson, 1984), whereas categorical variables are values that describe a 'quality' or 'characteristic' 
of a data unit, like 'what type' or 'which category'. Date formatted variables fall in the category 
categorical ordinal variables.  The list of the variables selected and a detailed description is 
presented in Section 6. Data on financial factors and supplier lead times was not licensed by the 
company. 
The variables selected for the study were subject to a correlation analysis between inventory metrics 
and three control variables. The aim of the analysis was to select the independent variable 
representing the stock levels at affiliates which would be used in the posterior analyses.  
The results, which are shown in Section 6, identified Strategic Stock and Safety Stock as the main 
target variables for the cluster analysis and Total Stock Quantity as the main target variable for the 
predictive modelling analysis. 
4.3.2.3. Data modelling: cluster analysis and predictive modelling methods 
Cluster Analysis 
In order to study the inventory configurations of the sample, the observations of the dataset were 
grouped into four clusters (groups) depending on their Safety and Strategic Stock levels.  
Figure 6. Iterative process to conduct the quantitative analysis 
4. Data cleansing 
and filtering 
3. Data 
exploration 
2. Data collection 
and preparation 
5. Data modelling 
and visualization 
6. Outcome 
evaluation 
Research 
question (RQ2) 
1. Business 
understanding 
  Article: Inventory Drivers in a Pharmaceutical Supply Chain                                                                                    Page 24 
 
The goal of performing a cluster analysis was to explore whether previously undefined groups 
existed in the dataset (Kaufman and Rousseeuw, 2005) and divide the multivariate dataset into these 
“natural” groups. The clustering analysis was conducted in two steps. First, a K-Centroids cluster 
analysis was performed using the K-Means method. The K-Centroids cluster analysis determines 
the appropriate number of clusters in which observations should be divided based on their similarity 
to each other and dissimilarity with the observations assigned to other clusters. The measure of 
similarity was based on Euclidean distances. The number of clusters was chosen by investigating 
the Adjusted Rand and Calinski-Harabasz Indices and selecting the number of clusters that had the 
highest Indices associated.  
The Adjusted Rand Index provides a measure of how similar the units within a cluster grouping are 
(Desgraupes, 2013). The Calinski-Harabasz Index, on the other hand, measures the distance 
between the defined groups and the compactness of the group (i.e. how close to the cluster centroids 
the observations are). Selecting the number of clusters with the highest Indices, therefore, ensures 
that the observations within the cluster present similarities and that groups are differentiated from 
each other.  
In a second step, the clusters were formed manually by investigating the median and quartile 
distributions of the variables Strategic Stock and Safety Stock and assigning a “High/Low” score to 
each of the observations for each of the two variables, thus creating two new binary variables: 
Strategic Stock Days H/L and Safety Stock Days H/L. The combination of the two possible values 
that each variable can take (H/L) determined the clusters in the sample, as indicated in Table 7. 
Table 7. Creating the clusters: High/Low Strategic and Safety Stock. ("H" stands for High and "L" stands for Low). 
Variable Sample 
Analysis 
High/Low Assign code Rationale 
Strategic Stock 
Days 
Q1: 0 
Median: 0 
Q3: 0 
Max: 360 
IF [StrategicStockDays]<10 
THEN [StrategicStock Days 
H/L]="L" ELSE "H" 
ENDIF 
Only a few products carry Strategic 
Stock in the case company, and the 
minimum Strategic Stock associated to 
a product is 10 DOH. See Section 5 for 
more details on strategic stock. 
Safety Stock Days 
Q1: 30 
Median: 36 
Q3: 45 
Max: 814 
IF [SafetyStockDays]<36 
THEN [SafetyStockDays 
H/L]="L" ELSE "H" 
ENDIF 
Observations below the median are 
assigned “L” (low Safety Stock), and 
above the median, “H” (high).  
Observations 
belong to one of 
the 4 clusters 
HH: High Strategic Stock and High Safety Stock 
HL: High Strategic Stock and Low Safety Stock 
LH: Low Strategic Stock and High Safety Stock 
LL: Low Strategic Stock and Low Safety Stock 
The analysis of the data within the clusters was then performed by measuring the central tendency 
of the data (represented by the medians) of the Strategic Stock, Safety Stock and Total Stock 
variables. The summary statistics were compared across the time period in which the sample was 
drawn in order to evaluate the evolution of the clusters in time. 
Predictive modelling and classification models 
The goal of the predictive modelling analysis was to determine the most meaningful parameters 
responsible for the inventory levels in the affiliates of the case study company. In the predictive 
modelling analysis, each cluster was exposed to Multiple Linear Regression Analysis (MLR) and 
Decision Tree (DT) models. The models investigated the relationship between the target variable 
(Total Stock Quantity) and a set of 7 independent variables.  
- Multiple Linear Regression Analysis (MLR) 
A Multiple Linear Regression Analysis is a statistical method that attempts to model the 
relationship between two or more explanatory variables and a response variable by fitting a linear 
equation to observed data (Aiken et al., 2003). Formally, the model for multiple linear regression, 
given n observations may be written as: 
(2)            𝑦𝑖  =  𝛽0  +  𝛽1 ∙ 𝑥𝑖1  +  𝛽2 ∙ 𝑥𝑖2 + . . . + 𝛽𝑛 ∙ 𝑥𝑖𝑛  +  ε𝑖        𝑓𝑜𝑟 𝑖 = 1, 2, … 𝑛 
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Where 𝑦 represents the dependent variable, 𝑥1 … 𝑥𝑚 represent the set of exploratory variables, β0…βm  
are the regression coefficients and e the random error term. The error term e represents the 
collective unobservable influence of any omitted variables (Freund and Wilson, 2006).  
The least-squares errors method, in which the best-fitting line for the observed data is calculated by 
minimizing the sum of the squares of the vertical deviations from each data point to the regression 
line (Aiken et al., 2003; Lacey, 2017) was used for estimation purposes in the MLR model.  
Test statistics were performed in order to determine the significance of the variables included in the 
regression. For any of the variables xj included in a multiple regression model, the hypothesis states: 
(𝑛𝑢𝑙𝑙) 𝐻0: 𝛽𝑖 = 0   (the coefficient is not statistically significant, thus zero) 
            𝐻1: 𝛽𝑖 ≠ 0    (the coefficient is significant) 
The significance level was set at 𝛼 = 0,05. With the dependent variable being Total Stock Quantity, 
the variables with regression coefficients different than 0 are considered relevant in determining 
inventory levels in the case study company. 
The MLR was performed for each of the four clusters using the Multiple Linear Regression tool in 
Alteryx®, where slight modifications in the R code were made to adjust the confidence interval 
range (and correspondent p-values) of the regression. 
- Decision tree modelling (DT): Regression Trees 
A Decision Tree model is a non-linear predictive model, namely prediction tree. The model can 
predict a target (dependent) variable using one or more predictor variables that are expected to have 
an influence on the dependent variable (Alteryx Inc., 2017). The model generates a set of if-then 
rules that segment data into different branches following a certain criterion. In the DT models 
performed, the criterion used to form these rules is the minimization the sum of the squared errors 
(LSE) at each split. 
The maximum allowed depth of any node in the final tree (maxdepth parameter in the R code) was 
set to 20. This option limits the overall size of the tree by indicating how many levels are allowed 
from the root node to the most distant node, thus preventing the tree from growing too large. For the 
same reasons, the number of observations required for a split search was set to 50 in two of the 
clusters (the most populated clusters). 
A major advantage of this modelling technique is that it produces a model which may represent 
interpretable or logic statements (Müller and Wiederhold, 2002). Decision trees especially perform 
well in large datasets, which is the case of this study. Furthermore, they do not require normality 
assumptions in the data, as they are non-parametric procedures. Another advantage is the fact that 
DTs can be built to predict continuous and categorical variables, which makes the results 
comparable to the multiple regression analysis methods. 
4.3.2.4. Model Selection criteria 
Two different procedures were used to determine the goodness-of-fit (accuracy) of the different 
models in each cluster. 
For the MLR models, the goodness-of-fit was assessed by means of the adjusted R-squared, which 
is an output provided by the statistical model in Alteryx®. The Adjusted R-Squared compares the 
explanatory power of regression models that contain different number of predictors (Minitab Inc., 
2016). The adjusted R-squared only increases if a new explanatory variable improves the model 
more than it would be expected by chance. Therefore, the models with highest adjusted R-squared 
measure were selected. Furthermore, residual plots were used to assess whether the observed error 
(residuals) of the MLR followed any pattern.  
Decision Tree models’ accuracy was measured with the pruning plot of the tree, which compares 
the tree size and the relative error between the observations in a node and the node value. Lower 
relative errors represent a higher accuracy of the model. 
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4.4. Validity of the research approach and validity of the framework 
Research based on a single case study approach has often been criticized for its lack of robustness, 
especially in collecting data and validating results (Kohlbacher, 2006). This section covers the 
validity of the research approach conducted and the validity of the theoretical framework 
developed. The validity of the research approach ensures the validity of the findings obtained. The 
validity of the theoretical framework ensures the replicability of the study in other pharmaceutical 
companies.  
4.4.1. Validity of the qualitative analysis: survey questionnaire and interviews 
The issues of reliability and validity are key considerations to evaluate the characteristics of the 
questionnaire as a measuring instrument (Brewerton and Millward, 2001). Reliability indicates the 
extent to which the questionnaire is exempt of biases, i.e. produces consistent data in measuring 
concepts (Vacha-Haase et al., 2000). Validity, on the other hand, indicates if the measurement tool 
actually measures the concepts it is intended to measure (Brewerton and Millward, 2001). 
The two most common types of validity in organizational research are content validity and construct 
validity (Brewerton and Millward, 2001). In this study, the following approaches were used to 
ensure the validity of the questionnaire results: 
(i) Validation with academics: the body of questions formulated in the survey are the result of 
an in-depth hypothesis formulation which derived from an extensive literature review. This 
approach ensures content validity. 
(i) Descriptive statistics: The medians and interquartile ranges of each factor were depicted in 
several boxplots; thus ensuring construct validity (i.e. the items of a construct measure do 
not measure multiple constructs or factors). 
Furthermore, the following set of practical considerations were applied to the construction of the 
survey in order to the ensure the reliability and accuracy of the data collected: 
1. Wording of the questions: The word NOT was avoided in negative statements.  
2. Use of multiple statements to measure several concepts (e.g. the set of questions no. 5) and 
allow the respondent to opt for a neutral option if they are not sure about the answer.  
3. Avoidance of double-binded statements. Instead, clarifications were inserted in brackets. 
The findings derived from survey questionnaires that employ likert scales are subject to provide 
biased results (Allen and Seaman, 2007; Bradburn et al., 2004), due to several causes: 
- Avoidance of using extreme response categories (usually referred to as central tendency bias).  
- Agreeing with statements as presented (acquiescence bias).  
- Respondents attempting to portray themselves or their organization in a more favourable light 
(social desirability bias). 
In order to overcome potential biased results, methodological triangulation methods were employed. 
Triangulation methods are suitable mechanisms to ensure validity in the research approach 
(Yin,1984). Methodological triangulation in the qualitative analysis was guaranteed by analysing 
some of the aspects presented in the survey by cross-checking the information in the interviews 
conducted. However, in order to ensure validity of the research approach, the validity of interview 
methods employed also needs to be guaranteed.  
In semi-structured interviews, individual subjective interpretation can lead to misleading findings or 
conclusions (Bharmani, 2005). In order to minimise the impact of potential biased information, a 
transcript of the interview was sent to the respondents shortly after the interview occurred. If any 
misinterpretation existed, this was clarified and corrected. Further tactics such as adopting different 
angles from which to look at the phenomenon (Yin, 2003), and cross-checking information with 
different informants were also adopted to construct validity in the interviews. 
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4.4.2. Validity of the quantitative analysis: validity of the statistical methods 
The validity of the quantitative analysis results depends on the validity of the methods employed. 
Statistical methods are suitable to pursue a quantitative approach, because they are firmly based on 
mathematical theories and gives the study a scientific basis which is easier to replicate by others  
(Densecombe, 2009). Furthermore, a quantitative approach gives the study a higher degree of 
credibility and reliability.  
Despite their usefulness, the statistical methods employed present some conceptual limitations: 
 In multi-linear regression techniques the method proceeds by assuming that the relationship 
between the independent and dependent variables is linear (Aiken, et al., 2003). Suitable 
transformations of the data were considered in order to attain linearity. However, since the 
focus was on determining the important variables impacting inventory levels and not the exact 
relationship; it was not necessary to perform these transformations.  
 Multi-linear regressions can be highly affected by the presence of outliers in the dataset (Aiken, 
et al., 2003). This potential problem was overcome by analysing and filtering the data prior to 
building the model, as detailed previously. 
 Another major conceptual limitation of all regression techniques is that one can only ascertain 
relationship between two variables, but can never be sure about underlying causal mechanism 
of this relationship. This is the reason why qualitative methods were employed to gain an in-
depth understanding of the underlying causes of the relationships between variables. 
 Decision-tree models overcome the non-linearity problem presented by regression techniques. 
However, they can become more difficult to interpret than regressions if the number of nodes in 
the tree grows too large. To overcome this potential problem, the maximum number of nodes in 
a tree was limited, as indicated previously. 
4.4.3. Validity of the developed framework 
According to Kirkpatrick (1959), conceptual frameworks require of a stringent process of 
validation. The IDM framework was validated through a feedback session carried among supply 
chain planners and specialists in the case study company. In total, 8 employees from the case 
company participated in the session. The validity session lasted one hour and allowed to explore the 
usefulness of the framework’s application.  
The workshop started with an introduction to the research topic and quantitative results obtained. 
Thereafter, a discussion was initiated on the importance scores received by each of the factors and 
challenging the impact score determined by the assessment made on the company’s supply chain 
configuration.  
Consensus among the workshop participants was found in selecting three focus areas of the 
framework where efforts should be placed in order to pursue inventory reduction strategies. Other 
findings from the feedback session include the agreement among participants in considering the 
framework a useful tool to facilitate discussions and consider a wide range of aspects which might 
not necessarily be quantitative. One of the critiques to the framework was the different abstraction 
levels of the factors considered. Further steps in refining the model could be done in order to 
separate the factors in different abstraction levels. 
While the developed framework was only validated using a single case study company, its 
usefulness could be further validated by replicating the framework’s application with several case 
companies and benchmarking the results obtained. 
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This section aims to provide an overview of each of the factors presented in the IDM framework by 
analysing the current supply chain characteristics of the case study company. The findings 
presented derive from the information obtained in the interviews conducted and an examination of 
internal documentation of the case study company. A transcript of the interviews is presented in 
Appendix B. 
5.1. Current affiliate configuration 
PharmaNordic is a global company which operates as a sales organization responsible for the 
production, supply, sales and distribution of diabetes drugs in more than 180 countries. 
PharmaNordic is currently developing processes to improve its inventory management approach 
and reduce the capital tied up in inventories in an international context by analysing inventory 
configurations in their affiliates and the factors impacting inventory levels. 
The flow of finished goods is from the production factories –placed in 7 different locations spread 
worldwide- to a shipping hub, where they are temporarily stored before being shipped to the sales 
affiliates owned by the company. From the sales affiliates, the products are then shipped upon 
request from the government, medical distributors or wholesalers which, in turn, distribute them 
through third party logistic providers (3PLs) or local distributors to the pharmacies and hospitals, 
where end customers can purchase the products. These final intermediaries also carry stock in their 
distribution networks, although PharmaNordic does not have a complete control on the stock held 
by these intermediaries. 
The current supply chain configuration in the case study company consists of an initial 
classification of its types of affiliates, which depends on their ability to order and hold products on 
stock. There are three types of affiliate: stockholding affiliates, consignment affiliates and customer 
consignment affiliates without own plant. The first two types of affiliates are able to order products 
from the central headquarters and stock them in their own warehouses. The latter is regarded as an 
“external customer” and does not hold products on stock. Consignment affiliates without own plant 
are usually regarded as intermediaries between PharmaNordic and its wholesalers. 
Furthermore, affiliates are classified into MRP countries and non-MRP countries. MRP stands for 
Material Requirements Planning and is the planning methodology used in PharmaNordic where the 
company centralises the responsibility of managing inventories in central planning functions located 
in the headquarters of the company in Denmark. The reason for having centralized supply chain 
functions is to have a better control of the flow of products and inventory levels, besides promoting 
an alignment between the supply and demand functions of the company. Figure 7 below depicts the 
current affiliate configuration in PharmaNordic. 
 
 
 
 
 
 
The MRP system breaks down inventory requirements into planning periods - daily, weekly or 
monthly and supports the global production prioritisation strategy of the company as a transparency 
tool. Table 8 below highlights the differences between MRP and non-MRP affiliates.  
  
5. Findings 
PharmaNordic Sales 
Affiliates 
MRP affiliates 
Non-MRP affiliates 
• Low demand volatility  
• Reliable GSF forecast (Accuracy >80%) 
• Stock-level visibility 
• Local distribution setup – 
 Frequency of shipments 
within 1 month 
• High Demand volatility (Low stability index) 
• GSF forecast accuracy < 80% 
• Low  Stock-level visibility 
• Local distribution setup  
 Variable shipments frequency 
Stock-holding affiliates 
Consignment affiliates  
Consignment affiliates 
without own plant  
Figure 7. Current affiliate configuration in the case study company. 
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Table 8. Differences between MRP and non-MRP affiliate 
MRP affiliates Non-MRP affiliates 
 Characteristics of the affiliate: 
 1. Low demand volatility 
 2. Forecast accuracy > 80% 
 3. High Stock level visibility 
 4. Weekly/monthly stock level movements need to 
be visible for the affiliate 
 5. Local distribution setup – Shipments frequency: 1 month 
 Characteristics of the affiliate: 
 1. Usually high demand volatility  
 2. Low Forecast accuracy: < 80% 
 3. Usually poor stock level visibility 
 4. Variable shipments frequency  
 
Better management of supplies 
Lower stocks and waste levels 
Improved responsiveness to changes 
Orders based on demand from the market 
Higher stock and scrap levels 
Less responsiveness to unexpected demand 
80% sales volume 
̴ 60 countries: Usually big countries, high and stable 
demands. 
20% sales volume 
̴ 110 countries: Small countries and developing 
economies. Dependent on tender offers. 
Stock and replenishment policies responsible: S&OP 
planners (Centralized in headquarter functions) 
Stock and replenishment policies responsible: Local 
Supply Chain Managers 
Inventory planning and control is made in centralised 
functions and systems (ERP systems), but the physical 
inventory is de-centralised locally at the affiliates. 
No centralised inventory control 
Types of orders: MRP, Lot for Lot, Cyclic and Manual Types of orders: Manual 
Production strategy: Make-to-stock policy (generally) Production strategy: Make-to-order policy (generally) 
5.2. The IDM framework: Application to the case study company 
5.2.1. Product Characteristics 
The product portfolio for diabetes products is relatively broad, consisting on a total of 12 
commercialised brands, which, in some cases are sold to different countries under different names 
due to regulatory constraints. Furthermore, differences in language affect the printed packaging 
materials (PPM) of the products, since they are customized per product type and per country. The 
core insulin product, however, does not differ. Therefore, product customization is considered to be 
medium-low.  
Product complexity, which is determined by the type of delivery systems and the packaging sizes in 
which the insulin products are commercialised can be considered high. Delivery systems are 
containers of the liquid insulin product (semi-finished product). There are 6 types of delivery 
systems for insulin products. The packaging sizes, which are determined in number of pieces per 
pack (pcs/pack) depend on the delivery system used and the type of product commercialized. 
The total shelf life of a diabetes finished product is approximately 20 months. The product shelf life 
policy is set at 70% of the total shelf life when the product reaches the affiliate in MRP countries. In 
some cases, shelf life requirements are of 75% or 80% of the total shelf life of the product. 
Production facilities are not measured in terms of delivering the product with the required shelf life, 
and sometimes deliver the products with lower shelf lives to the affiliates.  
The frequency of launches of products to new markets is relatively low if benchmarked with other 
industries, due to long lead times in new drugs approvals (especially in emergent markets).The 
portfolio rotation is low, given the long term duration of the patents and long R&D lead times. 
5.2.2. Internal Operation Capabilities 
Replenishment and planning processes in PharmaNordic for MRP countries are divided into three 
main processes that depend on the time horizon considered: Sales and Operations Planning (S&OP), 
Supply Network Planning (SNP) and Operational Planning (OP). Each planning process has its own 
procedures, tools and involves different stakeholders, and has different main activities and outputs. 
The S&OP is a semi-annual process where planning is done at an aggregated level. Its main outputs 
are the production capacity agreements for the production sites and sub-contractors and the country 
transfer master plan. It comprises a time horizon from half a year until 2 years ahead. The SNP is a 
monthly process where demand and supply are balanced via simulation techniques. 
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Its main outputs are (1) the forecasted demand, (2) adjusted parameters (Safety Stock and Reorder 
Point) and product categorisation, and (3) the levelled capacity at production sites. The SNP 
comprises the time horizon from the operational planning and up to 2 years. The SNP planning is 
the process where adjustments on safety stock levels are made. 
The purpose of the OP planning is that of creating the production schedules, control the limitation 
of variants and follow-up on materials and capacities in the production sites. Its main output is the 
release of a production schedule plan to a central system which is then transferred to the production 
sites. The Operational Planning is outside the frozen timeframe. The plan introduced to the 
production planning system is frozen and cannot (in general) be modified. 
The replenishment policy depends on the type of affiliate. MRP affiliates use the Inventory 
Management model, an internal tool based on a periodic review policy that calculates safety stock 
targets and reorder points for each affiliate. The tool takes into account the average demand of the 
past 6 months, the replenishment lead times, the standard deviation of demand for the same time 
period, the standard deviation of the lead times and the desired service level. Non-MRP countries 
place manual orders to production sites, usually based on a continuous review policy. Despite using 
a continuous review policy, non-MRP affiliate’s stock management is regarded as being worse than 
in MRP affiliates.  The orders placed by affiliates are divided into four planning categories during 
the SNP monthly process run. The order planning categories are classified in four groups according 
to sales volume and level of demand predictability (Figure 8). 
 
Figure 8. Order planning categories 
Order categories have a significant impact on the amount tied up on inventories in the sales 
affiliates and on the production capacity schedules in production facilities. Order categories 
determine the order sizes and thus, production schedules are made accordingly. Affiliates are 
required to order in minimum order quantity batches to production sites. The size of the minimum 
order quantities depends on the type of delivery system and the packaging size used. Lead times 
between when an order is placed by the affiliates until it is released (Order Lead Times) depend on 
each production site. Production sites are measured on different key performance indicators (KPIs) 
based on their ability to release these orders within the production lead time policies established by 
the company. PharmaNordic is currently pursuing a reduction in production lead times by focusing 
on supplier and order lead times (OLT) reduction in different production sites.  
Production capacity utilization is considered to be low. No data on capacity utilization was actually 
obtained. However, interviews with different stakeholders have revealed that for certain production 
sites, there is more capacity installed than demand. This has an impact on the production strategy of 
the company (make-to-order for non-MRP affiliates and make-to-stock for MRP affiliates). 
Business cases developed within the company show that MRP affiliates tend to carry more stock 
than non-MRP affiliates, although inventory levels at non-MRP affiliates is not always visible from 
the central planning functions. Inventory space does not play an important role in determining stock 
levels, according to interviewees. Space is merely considered a constraint in the situations when 
planners pursue a massive MTS strategy by advancing orders and pushing them to the affiliates. 
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5.2.3. Market Factors 
The replenishment plan is based on the demand forecast for each specific country made by the 
affiliates. The demand planning team, which is local, benefits from having closer contact with the 
sales department, thus obtaining more accurate demand inputs from each independent market.  The 
demand forecast is done at a product and market level in monthly buckets and then loaded into the 
replenishment planning system in weekly buckets. Demand sales data is updated on a monthly basis 
during the SNP process run. Even though all planning processes are based on historical demand 
data, the forecast accuracy is considered to be low. Forecast accuracy is estimated to be 
approximately 80% in MRP countries, whereas non-MRP countries have much lower levels of 
accuracy in their forecasts. Interviewees suggested that in reality, forecasts present lower accuracy 
percentages (70% accuracy). Seasonality is not a factor considered in the forecast, due to the nature 
of the products. Interviews with several stakeholders have revealed that demand accuracy is one of 
the focus points of the company going forward if lower inventory levels are to be attained. 
Demand variability is considered to be high, with non-MRP countries accounting for a big portion 
of the demand variability. This can be attributable to non-MRP countries’ sales being driven by 
tender offers. MRP countries, on the other hand, have more stable demands. Sales demand is highly 
dependent on promotions, rebates and the specific characteristics of each product. The overall 
supply chain strategy of the company is service level-driven and PharmaNordic aims to operate 
with an affiliate service level of 99.5% (i.e. the stock-out risk is 1 in 200 orders). The service level 
targets are set by top management as part of the supply chain strategy.  
5.2.4. Financial Factors 
Financial factors associated to stock management are undoubtedly important metrics that the 
financial organization of the company continually reviews and monitors. However, detailed 
financial data could not be accessed and the analysis of financial factors had to rely solely on the 
interviews conducted and internal documentation of the company (Figure 9). 
 
Figure 9. Cost allocation as a percentage of the supply chain related costs. Source: PharmaNordic internal 
documentation 
Interviews with several stakeholders revealed that transportation was the major supply chain cost, 
followed by storage and inventory handling costs. The company does not monitor scrap-related 
costs. The high prices of the products, however, make stock-out costs rise consistently. Consensus 
was found in considering stock-out costs as being more important than holding, scrap or order cost. 
5.2.5. Upstream and Downstream Supply Chain capabilities 
As a manufacturing company, PharmaNordic operates with two types of suppliers: internal 
suppliers (i.e. the own company) and third-party suppliers. Internal suppliers are the semi-finished 
products production sites. Since semi-finished products are key for the functioning of finished 
products manufacturing sites (assembly and pack sites), these are stocked in decoupling points. 
Semi-finished supplies are rarely scarce and do not represent a direct impact on FG-stock. 
This means that only suppliers for packaging materials take especial relevance in the finished-goods 
production processes. PPM materials are ordered to third party suppliers in bulks. The delivery 
frequency from suppliers is based on order requests from the production sites, centralized and 
bundled from the central planning functions in the headquarters. The lead time from suppliers can 
vary depending on each specific production site location. However, contracts for packaging material 
establish that suppliers have 22 days to deliver the PPM to production sites from the moment an 
order is placed. These 22 days account for approximately half of the production lead time.  
57%
19%
11%
8%
5%
Transportation costs
Storage costs
Inventory handling costs
3PL associated costs
Others
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On the downstream part of the supply chain, the set-up is more complex, as it depends on each 
individual market. The frequency of shipments is made weekly-bi-weekly for MRP countries, 
depending on the replenishment policies. For non-MRP countries, the shipment frequency can vary 
significantly. Additionally, the company expedites express shipments in order to avoid stock-outs 
when demand increases unexpectedly. PharmaNordic customers entail wholesalers, retailers and 
pharmacies, which also have their own distribution networks and warehousing structure. Thus, there 
is an unknown retailer lead time from the moment when a product is dispatched from an affiliate 
until the end-customer receives it, which also has an impact on the freshness of the product. 
Interviewees emphasized the importance of having more visibility on the stock held by these 
distributors, which could be crucial in managing inventories. 
De-coupling points have an important role in determining inventory levels. There are various 
decoupling points throughout the production and delivery chain in the case study company. The first 
one is the Active Pharmaceutical Ingredient (API) decoupling point, where insulin raw material is 
stored in cold chambers (18 months in stock). In addition, each semi-finished production site keeps 
3 months of API stock. The second decoupling point is held at filling production sites, where semi-
finished goods are stored. Finally, the affiliates constitute the final decoupling point, where 
customer orders are matched with a specific batch number when the order is placed to production 
sites. Outbound transportation from the shipping hub to the affiliates is made by sea or air freight.  
5.2.6. Cooperation and Managerial Factors 
Cooperation and managerial factors were found to receive less attention from a stock management 
perspective. Outsourced logistics have already been mentioned as indirectly driving high levels of 
safety stock. From the factors in the IDM framework, regulations requirements are key in 
PharmaNordic’s supply chain. These regulations impact the selection of production sites to produce 
a certain drug for a specific country (i.e. production sites receive approvals for manufacturing 
products for several countries, but some countries can have special requirements with regards to 
shelf life or production location). Some regulations also require the company to hold strategic stock 
in its affiliates, which has a direct impact on the amount held on stock. 
Within the current supply chain strategy, inventory control is not a top priority in the company. This 
is reflected in the KPIs used to measure the organization, which are focused on avoiding stock-outs 
and shipment speed, but do not set a limit on the amount held on stock in the affiliates.  
There is currently an on-going project determining the optimal degree of inventory centralization in 
the company, which is now considered to be highly de-centralized (inventories are held in multiple 
points throughout the delivery chain). The project, however, is in its initial stage and its 
implementation is yet in the long term horizon. 
5.3. Inventory configurations in the case study company 
PharmaNordic divides its inventories into two main configurations: safety stock and strategic stock.  
At PharmaNordic, safety stock is defined as: “(…) extra stock that is maintained to mitigate the 
risk of stock-outs due to uncertainties in supply and demand or manufacturing yield”. Safety Stock 
levels are determined by the Inventory Management (IM) Model, which bases the replenishment of 
all items at MRP affiliates on the actual safety stock levels registered by the ERP system for each 
item and country. Safety Stock and Reorder Point calculations are automatically performed during 
the SNP process. In addition, the S&OP team occasionally dictates an increase of the service levels 
by applying temporary safety stocks. This is done more often than what would be desirable. 
Strategic Stock is held only for items with annual turnovers higher than a certain limit. The strategic 
stock measured in Days On Hand (DOH) are stratified into 25, 20, 15 and 10 DOH for very high 
average item sales, high average item sales, medium average  item sales and medium-low average 
item sales respectively. The strategic stock policies are revisited during the S&OP half-year review. 
No specific distinction is made between cycle inventory and safety inventory at an affiliate level in 
the ERP systems: inventory configurations are only separated on safety stock and strategic stock. 
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The section is divided in two subsections covering the qualitative and quantitative analysis 
respectively. The first research question (RQ1) is answered by means of a qualitative analysis: the 
IDM framework is applied to the case study company using a survey questionnaire and an 
assessment of the inventory drivers is conducted based on the findings from the interviews. The 
quantitative analysis has determined the inventory configurations in the case study company, thus 
answering the second research question (RQ2). 
6.1. Determining inventory drivers (RQ1): a qualitative analysis 
6.1.1. The IDM framework: Importance score 
Using the IDM framework, survey respondents were able to indicate their prioritization among 
inventory drivers by allocating scores from 1 to 5 to each factor.  In order to identify the factors in 
the IDM framework that received the highest scores, two tests types were performed. The Kruskal-
Wallis test determined if any of the factors within a category was statistically scored higher than the 
rest of the factors. The second test consisted on a frequency analysis and boxplots containing 
descriptive statistics for each factor of the framework. Both tests were employed to determine the 
importance score of each factor; with the ultimate goal of determining the positioning of the 
company with regards to its inventory levels in comparison to the maximum overstock levels (see 
Table 11). Refer to Appendix A (Tables 2-9) for the complete survey results and R code developed 
to perform the tests. Table 9 below shows the hypotheses, results and conclusions derived from the 
Kruskal-Wallis tests. 
Table 9. Summary of Kruskal-Wallis tests performed within each category of factors 
Kruskal-Wallis Test: Comparison of medians within a category 
Hypothesis: H0: All the factors in the category have the same median; H1:The factors do not have the same median                     
 Category Result 
Conclusion: The medians for the factors 
within the category are… 
#1 
Production/Internal 
Operations 
Capabilities 
p-value = 0.09669 ̴  5% 
The null hypothesis can be rejected 
(but not with complete certainty). 
Results are ambiguous. Means can be 
statistically different. More investigation is 
needed.  
#2 
Product 
Characteristics 
p-value = 0.2844 >  5% 
The null hypothesis cannot be 
rejected. 
Statistically equal: all the factors within the 
category have the same importance/impact on 
inventory levels. 
#3 Market Factors 
p-value = 0.2892 > 5% 
The null hypothesis cannot be 
rejected. 
Statistically equal: all the factors within the 
category have the same importance/impact on 
inventory levels. 
#4 Financial Factors 
p-value = 0.003962 < 5% 
The null hypothesis can be rejected 
with a 95% degree of certainty. 
Not statistically equal: not all the factors within 
the category have the same importance/impact 
on inventory levels. 
#5 
Upstream SC 
Characteristics 
p-value = 0.036742 <5% 
The null hypothesis can be rejected 
with a 95% degree of certainty. 
Not statistically equal: not all the factors within 
the category have the same importance/impact 
on inventory levels. 
#6 
Downstream SC 
Characteristics 
p-value = 0.07729 ̴ 5% 
The null hypothesis can be rejected 
(but not with complete certainty). 
Results are ambiguous. Means can be 
statistically different. More investigation is 
needed.  
#7 
Cooperation and 
Managerial Factors 
p-value = 0.792 > 5% 
The null hypothesis cannot be 
rejected. 
Statistically equal: all the factors within the 
category have the same importance/impact on 
inventory levels. 
The results indicate that there is at least a clear perceived dominant factor within the categories 
Financial Factors and Upstream Supply Chain Characteristics (Tests #4 and #5), where the null 
hypothesis is rejected at p-values<0.05. For the categories Internal Operations Capabilities and 
Downstream Supply Chain Characteristics (Tests #1 and #6), the results are ambiguous at a p=0.05 
level, which means that some factors are dominating among the rest of the factors. This dominancy, 
however, needs to be explored in detail as the p-values are close to (but slightly greater than) 5%. 
Contrary to the expectations, the Kruskal-Wallis tests did not show statistically significant results 
for the following categories: Product Characteristics, Market Factors and Managerial Factors. The 
result is surprising, since at least one dominating factor was expected in each category.  
6. Analysis 
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A plausible explanation for this result might be that respondents perceived the factors within these 
categories as an entity and scored the factors with similar punctuations (Kruskal, 1952). 
In order to explore in greater depth the results obtained, several boxplots containing descriptive 
statistics for each factor were drawn (Figure 2 in Appendix B). The descriptive statistics used are the 
medians of the scores that survey respondents allocated to each factor of the framework.  
The results show that the most important inventory driver according to the survey respondents is 
Forecast Accuracy: 75% of the respondents gave this factor a score of 4 or higher, which confirms 
the results from the Kruskal-Wallis test.  Following, there are the factors with a median of 4: Order 
Quantity, Order Policy, Average Demand per Product, Demand Variability, Service Level, Stock-
out penalty costs, Lead Time Delivery to Customers and to Suppliers, Management’s attitude 
towards Inventory Control, Degree of Information Sharing across SC players and Degree of 
Centralization- Decentralization of Inventories.  
Particularly noticeable is the fact that four of the aforementioned factors belong to the category 
Market Factors (Figure 10): Average Demand, Demand Variability, Service Level and Forecast 
Accuracy. This result confirms the theories of Porter (1980), who states that market factors 
determine the external context for company operations and consequently, inventory decisions. 
While the first three factors are usually embedded in optimal stock calculation formulas, Forecast 
Accuracy is rarely (but should) be taken into account (Holm et al., 2016).  
  
Figure 10. Medians of the scores for each factor: Market Factors and Product Characteristics categories 
The results also underpin the importance of the factors Order Quantity and Order Policy, both 
within the Internal Operations Capabilities category. As appointed by a vast amount of literature, 
these two factors play a crucial role in determining inventory levels. In particular, smaller batch 
sizes lead to more efficient and less costly purchase orders, which tends to reduce unnecessary 
inventory levels (Shields, 2006). Furthermore, make-to-stock manufacturing increases inventory 
levels, whereas make-to-order policies are more flexible, allowing companies to hold less 
inventories. However, make-to-order policies may occasionally imply an increase in lead time and 
negatively impact inventories. 
The importance of Lead Time delivery to customers is also explained by literature. A number of 
classical inventory models and empirical studies show that the reducing cumulative lead times 
results in less inventory without the risk of impacting customer service (Shields, 2006), especially 
in global supply chains in which suppliers and customers are located far from each other 
(Lieberman and Deemester, 1999). In this case, both groups of respondents placed equal importance 
to this factor (see Figure 10). The importance of the Degree of Information Sharing within and 
between supply chain players has been regarded as vital in managing inventories efficiently (Lee et 
al., 2000; Cachon and Fisher, 2000), which is in line with the survey results. Especially relevant in 
this context is the use of information technology and managerial improvements (Demeter and 
Golini, 2014), which is linked to the factor Management’s attitude towards Inventory Control, as 
outlined by Lieberman et al. (1996). The latter also received high scores.  
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On the low importance side the factors Inventory Space, Material Costs, Order Costs and Holding 
Costs, are especially remarkable for its low median score (medians lower than 2,5). The results 
suggest that survey respondents found these factors less important in determining inventory levels 
and contrast with traditional scholar research done exclusively on the impact of costs on inventory 
(Cachon and Zipkin, 1999; Bragg, 2005; Christopher, 2005). The factors Outsourced Logistics and 
Type of Transportation were also deemed as being less important in driving inventory levels. 
However, this is not surprising, as not abundant literature was found on these particular factors. 
Only Ekstrand and Karlsfre (2012) mention that different transportation methods depend on item 
cost and volume, lead times and component variation; all of them considered in the IDM 
framework.  
If the factors of the IDM framework are examined in aggregate, Market factors is the highest rated 
factor category by the two groups of respondents (Figure 11). Following the Market Factors 
category there are the Upstream and Downstream Supply Chain Characteristics, Cooperation & 
Managerial Factors, Internal Operation Capabilities, Product Characteristics and Financial 
Factors categories respectively in this order. 
The relative weight of the categories in the IDM framework is shown in Figure 11. 
 
Figure 11. Weight of categories in the IDM framework 
While the two groups of respondents show similar decision patterns when allocating weighting 
scores, there are some minor differences in their prioritization of categories. On the one hand, 
planners placed equal importance on Internal Operations Capabilities and Downstream SC 
Characteristics, whereas managers and SC specialists prioritized Downstream SC Characteristics 
and Cooperation & Managerial factors. This result is consistent with the role descriptions of both 
groups and the definition of S&OP processes (Chopra and Meindl, 2007), where the fundamental 
purpose is to bring the demand and supply management functions of the company together. 
Supply chain managers and specialists have a broad overview on the supply chain operations in the 
company, since they lead a broader range of projects. Instead, planners at the case study company 
focus on specific products, usually having a narrower vision on specific processes related to 
production operations. The aforementioned is a likely cause for planners placing higher scores on 
Product Characteristics over the Financial Factors category, whereas managers and SC specialists 
prioritized Financial Factors. Furthermore, planners’ responses were more oriented towards 
Production Capabilities factors than supply chain managers’. 
6.1.2. The IDM framework: Impact score 
In order to determine the impact score, an assessment of each of the factors presented in the IDM 
framework was made by examining the findings in the current supply chain configuration of the 
case study company. The assessment was furthermore mapped with the impact that each factor had 
on the inventory levels in the case study company: 1 if the factor pointed towards high inventory 
levels, 0 if the factor was neutral in impacting inventory levels and -1 if the factor pointed towards 
reducing inventory levels, according to the table presented in the literature review (Table 1). The 
assessment was performed in two scenarios: an AS-IS scenario situation (with the current supply 
chain setup) and a TO-BE scenario, where the impact of certain factors was lowered to 0 if 
improvement suggestions were identified by the interviewees.  
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The assessment of both scenarios was made based the information obtained in the interviews 
conducted and mapping each factor’s performance with the impact found in the literature review, as 
shown in Figure 12. The results of the assessment are presented in Table 10. 
 
 
 
 
 
 
Table 10. Remarks of the case analysis: impact assessment of the factors in the IDM framework 
Impact score 
Factor Remarks of the case analysis: impact assessment according to literature   
Order 
quantity / 
Order size 
Affiliates are required to order in Minimum Order Quantities, in order to facilitate economies of 
scale in production. However, this MOQ are not considered high, if benchmarked with similar 
industries. The factor points towards neutral inventory levels. 
0 0 
Replenishme
nt policy 
The company uses both continuous review in non-MRP affiliates and period review policies in 
MRP countries. Given that MRP countries account for the majority of the large orders, the factor 
points towards high inventory levels.  
1 0 
Capacity 
utilization 
The company currently operates under an excess of capacity in some of the production sites. 
This, according to literature, points towards high inventory levels.  
1 0 
Production 
flexibility 
Machine flexibility to produce different product types, with the ability to adjust for different 
processes is considered high according to interviewees (for assembly and pack processes). Thus, 
this factor points towards low inventory levels. 
-1 -1 
Lead time Lead time from when affiliates place an order until it is released form production is considered to 
be high and, according to the stakeholders interviewed, could be reduced by revieweing 
production lead time policies. Pointing towards high inventory levels.  
1 0 
Lead time 
variance 
Lead time uncertainty is considered high. It depends on order sizes, the specific country from 
which the order is placed and the production sites where orders are manufactured, among other 
factors. Pointing towards high inventory levels. 
1 1 
Production 
strategy 
The production strategy is a MTS for MRP countries, and MTO/ATO for non-MRP countries. 
As MRP countries account for the majority of the volume, the factor points towards high 
inventory levels.  
1 0 
Inventory 
Space 
The space dedicated to store, handle and manage inventories is considered to be adequate. Thus 
the factor points towards neutral levels of inventories. 
0 0 
Product 
customization 
Products are customized for each specific country, with customization affecting packaging 
materials; however, the core insulin product does not differ. Pointing towards neutral levels.  
0 0  
Product 
complexity 
Product complexity is considered to be high; if determined by the type of delivery systems and 
the packaging sizes in which the insulin products are commercialised; thus pointing towards high 
inventory levels.  
1 0 
Shelf life High shelf life requirements from the affiliates urge the company to circulate products faster; 
thus pointing towards low inventory levels. 
-1 1 
Average 
demand 
Demand has been steadily increasing the last past years. The assessment points towards high 
inventory levels. The factor impact cannot be reduced because it depends on customers. 
1 1 
Demand 
variability 
Demand variability is considered to be high, with non-MRP countries accounting for a big 
portion of the demand variability. Therefore, the factor points towards high inventory levels. 
1 1 
Forecast 
accuracy 
Forecast accuracy is estimated to be low in comparison with other similar industries, according 
to interviewees. Forecast accuracy is worst in non-MRP countries than in MRP countries. The 
factor clearly points towards high inventory levels.  
1 0 
Forecasting 
frequency 
Forecasting frequency depends on the SNP monthly process run, which is in line with the policy 
guidelines. Some interviewees, however, suggested that forcast frequency should be increased. 
Therefore, the factor is ambiguous in determining inventory levels.  
0 0 
Service level The overall supply chain strategy of the company is service-level driven and the company aims 
to operate with an affiliate service level of 99.5%.The service level is set by top management as 
part of the supply chain strategy. Temporary safety stock increases service levels even more; 
thus clearly pointing towards high inventory levels.  
1 0 
Sales channel  The diverse contract types, especially in non-MRP countries points towards high stock levels. 1 1 
Product The commercialised products account for high prices, especially in developed countries. Profit -1 -1 
Impact score for each factor (1, 0 or -1) 
Interviews 
Internal documentation 
Assessment of factors in the IDM framework Literature review (Table 1) 
Findings 
AS-IS TO-BE 
AS-IS TO-BE 
Figure 12. Process followed to determine the impact score 
AS-IS │ TO-BE 
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price/unit  margins in developing economies are more moderate. High product prices lead to lower 
inventory levels according to literature; thus pointing towards low inventory levels. 
Material cost 
High material costs, which is the case of the company, lead to lower inventories in order to 
reduce financial associated risks; thus pointing towards lower inventory levels. 
-1 -1 
Order cost 
The costs associated with placing an order by the affiliates is relatively low (or negligible, in 
case of MRP affiliates). This factor points towards high inventory levels. 
1 1 
Holding cost The stock holding cost, which is low compared to stock-outs, points towards high inventories. 1 1 
Stock-out 
penalty cost 
The stock-out penalties, which are not only measured in financial terms, are considered to be 
extremely high and usually equal the price at which the product is sold. Furthermore, costs 
associated to the risk of losing customers in the future, makes this factor especially important. 
Therefore, the factor points towards high inventory levels.  
1 0 
Scrap cost 
Scrap costs are ambiguous on its impact on inventory levels. Scrap at non-MRP affiliates is not 
measured form the central HQ functions. Thus pointing towards neutral inventory levels. 
0 0 
Transportatio
n cost  
Transportation costs are related to factors such as item cost and volume, component variation, 
lead time and inventory interest rates. They are regarded as high due to the transportation 
methods the company uses (usually involving airfreight); pointing towards high inventory levels. 
1 1 
Delivery 
performance 
suppliers 
The case company has established close relationships with some suppliers, however, due to the 
high product complexity, supplier reliability cannot be considered to be high enough. Thus, the 
assessement is ambiguous; pointing to neutral inventory levels.  
0 0 
Delivery 
frequency 
suppliers 
The delivery frequency from suppliers is based on order requests from production sites, 
centralized and bundled from the central planning functions in the HQ. The delivery frequency is 
considered to be high enough, thus pointing towards low inventory levels. 
-1 -1 
Suppliers’ 
discounts 
Data could not be obtained for this factor. Therefore, it has been assessed as neutral in 
determining inventory levels. 
0 0 
Lead time 
delivery from 
suppliers 
Lead time from suppliers can vary depending on each specific production site. However, the lead 
time for the PPM accounts for half of the production lead time; thus this factor points towards 
high inventory levels.  
1 0 
Lead time 
delivery to 
customers 
The frequency of shipments is made weekly-bi-weekly for MRP countries, depending on the 
replenishment policies. For non-MRP countries, the shipment frequency can vary as much as 
once per month to once every three months. There is an unknown retailer lead time from the 
moment when a product is dispatched from an affiliate until the end-customer receives it; thus 
pointing towards high inventory levels. 
1 1 
Decoupling 
point position 
There are various decoupling points throughout the production and delivery chain. However, the 
impact of this factor in this particular case company is ambiguous: on the one hand, the 
decoupling point is used to customize the orders placed by the affiliates and therefore, lower 
inventory levels. On the other hand, multiple decoupling points lead to more stocking areas. 
0 0 
Type of 
transportation 
Outbound transportation from the shipping hub to the affiliates is made by sea freight or air 
freight, usually using a FTL strategy. Therefore, the factor points towards high inventory levels, 
according to literature. 
1 1 
Outsourced 
logistics 
The final distribution stages are outsourced to 3PLs and external distributors. A high degree of 
outsourcing has an impact on the visibility and control of the products. Interviewees emphasized 
the importance of having more visibility on the stock held by these distributors, which points 
towards high stock levels. 
1 1 
Lean supply 
chain 
capabilities 
The company does not follow lean principles in managing its finished-goods inventories. It does 
apply the principles at early stages of the production activities; however, these do not have an 
impact on FG inventories. The overall factor points towards high inventory levels. 
1 1 
Personal bias 
The accumulated impact of non-desired behaviours derived from the goal of achieving KPI 
performance leads to higher inventory levels.  
1 0 
Management 
attitude 
towards IC 
Within the current supply chain strategy, inventory control is not a top priority in the company. 
This is reflected in the KPIs used to measure the organization, which are focused on avoiding 
stock-outs and shipment speed, but do not set a limit on the amount held on stock in the 
affiliates. This clearly points towards high inventory levels. 
1 1 
Degree of 
employee 
training  
No data on this factor was accessible. Interviewed stakeholders did not provide a clear 
assessment of the factor; thus the factor was regarded as neutral in determining inventory levels. 0 0 
Information 
sharing 
Information sharing across supply chain players has been regarded as being improvable. Within 
the organization, stock at non-MRP countries is not visible from HQ functions. Local Supply 
Chain Managers in these countries have visibility, but there are no ERP systems connected to 
central/HQ functions. Thus, the factor points towards high inventory levels.  
1 0 
Degree of 
centralization
/de-
centralization 
The inventory planning and control functions are centralized in the HQ with the use of ERP 
systems in MRP affiliates, but the physical inventory is de-centralised locally at the affiliates. 
For non-MRP countries, both the planning functions and physical inventories are de-centralised 
locally; thus pointing towards high inventory levels.  
1 0 
Regulatory 
constraints 
Regulations imposed by governments and drug administration’s determine the selection of 
production sites to produce a product for a specific country; pointing towards high inventories. 
1 1 
*Factors highlighted in grey could reduce their impact from (1) to at least (0), according to interviewees. 
They constitute the focus areas. 
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6.1.3. Stocking positioning of the case study company 
The objective of the qualitative analysis is to determine the most important inventory drivers and 
the overall impact on inventory levels in the current (AS-IS) situation and the achievable (TO-BE) 
situation. Based on the results of the survey analysis, each factor was assigned an importance score 
based on a 5-point scale. The factors were furthermore assigned an impact score, based on the 
impact assessment made in Table 10. The combination of both scores determined the stock 
positioning of the company with regards to inventory levels in comparison to the maximum 
overstock levels in a normalized scale. The summary of the impact and importance score, and the 
total scores obtained in both scenarios are presented in Table 11. 
Table 11. Total impact of the different inventory drivers and focus areas identified (■)  
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■ Replenish. policy 4 1 4 0 0         
■ Capacity utilization 3 1 3 0 0  0 0 0 0 3 Delivery performance 
Product. flexibility 3 -1 -3 -1 -3  -3 -1 -3 -1 3 Delivery frequency 
Suppliers  ■ Lead time 3 1 3 0 0  0 0 0 0 2 Discounts suppliers 
Lead time variance 3 1 3 1 3  0 0 4 1 4 Lead time delivery from 
suppliers ■ 
■ Production strategy 3 1 3 0 0        
Inventory space 2 0 0 0 0         
5
- 
P
ro
d
u
c
t 
C
h
a
ra
c
te
r
is
ti
c
s 
      0         
Product 
customization  
3 0 0 0 0  4 1 4 1 4 Lead time delivery to 
customers 
Product complexity 3 1 3 1 3  0 0 0 0 3 Decoupling point 
position Shelf life 3 -1 -3 -1 -3  2 1 2 1 2 Type of transportation 
   0   0         
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Demand variability 4 1 4 1 4         
 ■ Forecast accuracy 5 1 5 0 0  2 1 2 1 2 Outsourced logistics 
Forecast horizon 3,5 0 0 0 0  3 1 3 1 3 Lean SC capabilities 
 ■ Service level 4 1 4 0 0  0 0 3,5 1 3,5 Personal bias ■ 
Sales channel type 3 1 3 1 3  4 1 4 1 4 Managem. att. towards 
IC  
6
- 
F
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l 
F
a
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s 
Product price/unit  3 -1 -3 -1 -3  0 0 0 0 3 Degree employee 
training &empower. Material cost 2 -1 -2 -1 -2  0 0 4 1 4 Information sharing ■ 
Order cost 2,5 1 2,5 1 2,5  0 0 4 1 4 Degree of centralization 
■ 
Holding cost 2,5 1 2,5 1 2,5  3,5 1 3,5 1 3,5 Regulatory constraints 
 ■ Stock-out cost 4 1 4 0 0         
Scrap cost 3 0 0 0 0         
Transportation cost  3 1 3 1 3         
 Total Score  40 14  15,5 31  Total Score  
   
TO-BE  AS-IS 
Total Score (Importance x Impact) 29,5  71 Total Score (Importance x Impact) 
Total Potential Score (If all factors pointed towards 1) 125,5  125,5 Total Potential Score (If all factors pointed towards 1) 
Inventory levels (TO-BE) 24%  57% Inventory levels (AS-IS) 
 
  
AS-IS stock positioning 
57% 
TO-BE stock positioning 
24% 
Min. inventory levels Max. inventory levels 100% overstock 0% overstock 
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6.2. Determining inventory configurations (RQ2): a quantitative analysis 
The results of the quantitative analysis are highlighted in this section. First, the variables used to 
perform the analyses are presented. Next, the second research question (RQ2) is answered by 
examining inventory configurations and their evolution in the case study company. Finally, the 
stock levels in each configuration are regressed against a number of factors in order to determine 
the impact these factors have on different inventory configurations in the case study company.   
To perform the quantitative analysis inventory data from different affiliates was collected from the 
case study company as indicated in the methodology section. The variables contain information on 
stock metrics, production-related factors, product characteristics and market-related factors.  
The variables, measures and units used are presented in Table 12 hereunder. 
Table 12. Categorical and numerical variables used in the quantitative analysis 
 
Variable Code 
Variabl
e Type 
Description 
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Inventory Week IWK Date-
formatt
ed 
Week in which the specific material number (Finished good product) is recorded 
to be on inventory. The format of the records is: YYYY-WW (year-week). E.g. 
201619 would correspond to week 19 in 2016. 
Material Number Mat String Special identifier that relates a specific product in a particular affiliate with the 
batch in which it was produced. 
Top Site TS String Production site where the specific material number has been produced (packed). 
There are 7 possible Top Sites worldwide: CLMO, CH, CL, HI, KA, MOC, TJ. 
Country CT String Country to which the sales affiliates belong. Note that one sales affiliate can 
serve several neighbour countries. 
Sales Region SA String Internal sales region as codified in the case study company. It refers to how the 
company divides its sales affiliates into sales regions. There are 6 sales regions. 
Delivery System DS String Type of device in which the insulin is delivered. There are 5 possible Delivery 
Systems: DS1, DS2, DS3, DS4, DS5. 
Brand Name  BN String Name under which the product is commercialized: 12 commercial names. These 
have been grouped under 8 groups, as some brand names vary depending on 
the amount of product (or dose). 
N
u
m
e
ri
c
a
l 
v
a
ri
a
b
le
s
 
Safety Stock 
Quantity /Days 
SSQ Double Extra stock that is maintained to mitigate the risk of stock-outs due to 
uncertainties in supply and demand. Units: EA and DOH. 
Strategic Stock 
Quantity / Days 
SGSQ Double Stock that is held only for items with annual turnover higher than a certain limit. 
Units: EA and DOH. 
Maximum Stock 
Quantity / Days 
MSQ Double Maximum Stock Level target at a sales affiliate level on a weekly basis per Brand 
or product type. Units: EA and DOH. 
Minimum Stock 
Quantity / Days 
MISQ Double Minimum Stock Level target at a sales affiliate level on a weekly basis per Brand 
or product type. Units: EA and DOH. 
Flag Out of 
Stock 
SOUT Binary Signals stocked-out items at an affiliate level on a weekly basis per Brand 
(Product Type). Takes the value 1 if the observation is at stock-out that week.  
Flag Above Max 
Stock 
ABOVE Binary Signals the items above the maximum stock target set for that specific product, 
affiliate and week. Takes the value 1 for above-maximum target items. 
Stock On Hand 
/Days on Hand 
DOH Double Actual stock on inventory with Batch Quality Status Released at production sites. 
Can be understood as production throughput. 
Total Stock 
Quantity / Days 
TSSQ Double Stock held at the affiliates, as a sum of the safety stock quantity and the strategic 
stock quantity. Units: EA and DOH. 
 U1U3 Factor  U3U1F Integer Pack size of the product: 1, 2, 3, 5 or 10 products per sales pack. 
 Order Size  OQ Double Size of the order placed by the affiliates in that replenishment period in units.  
 Lead Time Polic LT Integer Lead time policy per product and production site in days. 
 Avg. Daily 
Demand  
AVGD Double Demand from affiliate sites. Specific per affiliate and product type. Units: EA. 
    *Variables highlighted in grey were used in the predictive models 
    DOH: Days on Hand; EA: units of product 
6.2.1. Preliminary analysis: Variable selection by means of correlation analysis 
The preliminary analysis consisted of a correlation analysis between inventory metrics (SSQ, 
SGSQ, MSQ, MISQ, SOH, TSSQ) and three control variables (U3U1F, OQ and AVGD). Table 13 
summarizes the correlations among the nine variables.   
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Table 13. Correlation analysis results 
Strong positive correlations  
(ρ > 0.8) 
Medium-Low correlations  
(0.4 < ρ < 0.8) 
Negative Correlations  
(Inverse relationships) (ρ < 0) 
(MSQ — TSSQ, SSQ, AVGD, SOH) 
(TSSQ — SSQ, AVGD, SOH) 
(SSQ — AVGD, SOH) (AVGD — SOH) 
(OQ — SGSQ, MSQ, TSSQ, SSQ, 
AVGD, SOH) 
(SGSQ — OQ, MSQ, TSSQ) 
(U1U3F — SGSQ, OQ, MSQ, 
TSSQ, SSQ, AVGD, SOH) 
Significant positive correlations were found between the Maximum Stock Quantity, Total Stock 
Quantity, Safety Stock Quantity and Stock On Hand variables. This was expected since the sum of 
the Strategic Stock Quantity and Safety Stock Quantity form the Total Stock Quantity variable. 
Correlations higher than 0.8 were also found between Total Stock Quantity — Avg. Daily Demand 
and Safety Stock Quantity — Avg. Daily Demand. This result was anticipated, because MRP 
countries use the forecasted demand to compute the safety stock in each affiliate. Order sizes were 
found to have a medium to low correlation with the rest of stock variables. Negative correlations 
were found between the packaging size of the products (U3U1F) and the rest of the variables. 
Finally, given the relative low correlation between order size (OQ) and packaging size (U3U1F) and 
the theoretical difference between the two concepts, the variables were deemed to be independent. 
The strong correlation between the variables Total Stock Quantity, Safety Stock Quantity and 
Strategic Stock Quantity underpinned the selection of Strategic Stock Days and Safety Stock Days 
as main target variables for the investigation of inventory configurations and the selection of Total 
Stock Quantity as a main dependent variable for the posterior predictive analysis. The complete 
results and output from the Alteryx® software can be found in Table 12 of Appendix C. 
6.2.2. Cluster analysis: Inventory configurations in the case study company 
The objective of the cluster analysis was to determine the inventory configurations within the data 
sample and the key drivers behind them (RQ2). 
The results of the K-Means clustering algorithm (Figure 13) suggested to divide the sample in four 
clusters (cluster with the highest Adjusted Rand and Calinski-Harabasz Indices). 
  
Figure 13. Output of the K-centroids cluster analysis 
Next, the clusters were formed manually by creating two new binary variables and assigning a “H” 
or “L” (High/Low) label to each of the observations according to their Strategic Stock and Safety 
Stock levels, as detailed in the methodology section. The combination of the two possible values 
that each variable can take (High/Low) determined the clusters in the sample:  
Cluster 1: HH (High Strategic Stock and High Safety Stock) Cluster 3: LH (Low Strategic Stock and High Safety Stock) 
Cluster 2: HL (High Strategic Stock and Low Safety Stock) Cluster 4: LL (Low Strategic Stock and Low Safety Stock) 
The Alteryx® code for the cluster configurations is detailed in Figure 7 of Appendix C. 
In order to study evolution of the cluster’s composition, the observations of the sample were divided 
among the four clusters created for each year (2015-2017 YTD). The median of the Strategic, 
Safety and Total Stock were computed, as shown in Table 14. Furthermore, the number of stock-
outs and the number of observations above the Maximum Stock Level target KPI were computed as 
a percentage of the total number of observations in the cluster (% cluster observations). 
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Table 14. Descriptive statistics of the four clusters identified. Units: Median DOH.  
 
Cluster
s 2015 
# 
obs. 
Median DOH 2015 
Strategic | Safety | 
Total 
Strategic 
Stock 
(DOH) 
Safety 
Stock 
(DOH) 
Total 
Stock 
(DOH) 
Stock-outs 
(% of 
cluster 
obs.) 
Above 
Max Stock 
(% cluster 
obs.) 
2
0
1
5
 
HH 1017 
 
15 41 55 0,00% 3,64% 
HL 2149  15 30 44 0,00% 11,31% 
LH 
1092
6  
0 45 45 0,41% 7,61% 
LL 8747  0 30 30 0,34% 9,20% 
 
Cluster
s 2016 
# 
obs. 
Median DOH 2016 
Strategic | Safety | 
Total 
Strategic 
Stock 
(DOH) 
Safety 
Stock 
(DOH) 
Total 
Stock 
(DOH) 
Stock-outs 
(% of 
cluster 
obs.) 
Above 
Max Stock 
(% cluster 
obs.) 
2
0
1
6
 
HH 971 
 
15 42 64 0,00% 8,34% 
HL 3038 
 
15 30 43 0,13% 12,67% 
LH 
1058
6  
0 45 45 0,38% 9,11% 
LL 9726  0 30 30 0,37% 11,18% 
 
Cluster
s 2017 
# 
obs. 
Median DOH 2017 
YTD 
Strategic | Safety | 
Total 
Strategic 
Stock 
(DOH) 
Safety 
Stock 
(DOH) 
Total 
Stock 
(DOH) 
Stock-outs 
(% of 
cluster 
obs.) 
Above 
Max Stock 
(% cluster 
obs.) 
2
0
1
7
 Y
T
D
 HH 575 
 
15 44 65 0,00% 5,57% 
HL 924  15 30 43 0,22% 16,13% 
LH 4365  0 46 46 0,09% 10,70% 
LL 3925  0 30 30 0,10% 7,41% 
The results suggest that the most populated clusters are those that have low strategic stock levels 
(LH and LL), which together account for a total of approximately 86% of the sample’s population 
each year. This was expected; as the case study company only builds strategic stock for certain 
strategic products. As a rule of thumb, Strategic Stock accounts for 23%-27% of the Total Stock in 
days for the HH cluster, and between 23% and 35% in the HL cluster (a much broader range). 
However, it can be observed that the relative composition of the clusters slightly changes over time. 
6.2.2.1. Change in inventory configurations over time 
In order to determine if the clusters are stable over time (i.e. Safety Stock, Strategic Stock and Total 
Stock increase or decrease over the three years in which the sample is drawn), the medians for each 
of the inventory types were depicted across 2015, 2016 and 2017 YTD, as shown in Table 15.  
Table 15. Relative cluster composition (2015, 2016 and 2017 YTD). 
 
Clusters HL and LL are the more stable ones. The cluster configurations remain stable across the 
three years for the cluster LL in terms of Strategic, Safety and Total Stock. Cluster HL sees its 
Safety Stock decrease by a median of 1 day in 2016 (from 44 to 43 DOH), which is not a significant 
decrease. Clusters HH and LH, on the other hand, present different configurations over time. 
Interestingly, Safety Stock and as a consequence, Total Stock increases for clusters HH and LH. 
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Cluster HH sees its Total Stock increase with a relatively steep slope from 2015 to 2016, and with 
less intensity from 2016 to 2017. The Strategic Stock measure remains stable for all the clusters, 
being the median 15 DOH in the HH and HL clusters and 0 in the other two clusters. 
The findings of the current study differ from the findings of Demeter and Golini (2014), who 
proved that inventory configurations are stable and consistent over time, in terms of the levels of 
each type of inventory. However, their study focuses on assembling industries1, which might 
explain the difference in the findings. 
When comparing the evolution of stock levels with the number of observations that have been 
reported as stock-outs, it is interesting to notice that clusters which see their total stock increase, 
also observe a reduction in the percentage of stock-outs. At the same time, the number of 
observations above the maximum stock level see an increase in the same time periods. As it was 
expected, the HH cluster does not present any stock-out in any of the years studied. Clusters LH and 
LL present similar levels of stock-out items across the time period studied. One unanticipated 
finding was that cluster HL presents less stock-outs than cluster LH. Hence, it can conceivably be 
hypothesized that the percentage of stock-out observations is not correlated to high safety stock 
levels, but to strategic stock. 
Another finding stemming from the analysis is that no pattern can be observed between the number 
of stock-outs and the percentage of observations above the Max Stock Level target. This indicates 
that despite having high amounts of stock, the company is not able to achieve 100% service levels 
in its affiliates (i.e. reduce the number of stock-outs to 0). 
Finally, the results in Table 15 show that year 2017 presents significantly lower stock-out 
percentages and higher number of observations above the maximum level target. This can be 
partially explained by the fact that year 2017 only considers the first 21 weeks of the year. The 
interviews conducted revealed that production sites tend to advance orders and push the products to 
the affiliates at the beginning of the year in order to be able to comply with the production capacity 
agreements, which is confirmed from the data. 
With all the aforementioned, the second research question (RQ2) can now be answered. The cluster 
analysis has identified four inventory configurations in the case study company: HH, HL, LH and 
LL. Inventory configurations are relatively unstable over time over time, especially in clusters with 
high safety stock (HH and LH), which experience an increase in Safety Stock and thereafter, Total 
Stock. The number of stock-out items has been reduced during the three-year time period, whereas 
the number of observations above the maximum stock level (as a percentage of the total number of 
observations) increases for all the clusters across the three years. Finally, there is no correlation 
between having high safety stock levels and achieving higher service levels. 
6.2.2.2. Affiliate classification among clusters 
The affiliate classification among the clusters formed (Figure 14) complements the inventory 
configurations analysis. The relative positioning of a country within an axis of the matrix was 
computed as indicated in formulas (1) and (2): 
 (1)    𝑋𝑎𝑥𝑖𝑠  → 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛𝑖𝑛𝑔𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝑖 =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛𝑠 𝑤𝑖𝑡ℎ 𝑆𝑎𝑓𝑒𝑡𝑦 𝑆𝑡𝑜𝑐𝑘 𝐷𝑎𝑦𝑠 = "𝐻"𝑖
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑏𝑠𝑒𝑣𝑎𝑡𝑖𝑜𝑛𝑠𝑖
 
(2)    𝑌𝑎𝑥𝑖𝑠  → 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛𝑖𝑛𝑔𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝑖 =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛𝑠 𝑤𝑖𝑡ℎ 𝑆𝑡𝑟𝑎𝑡𝑒𝑔𝑖𝑐 𝑆𝑡𝑜𝑐𝑘 𝐷𝑎𝑦𝑠 = "𝐻"𝑖
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑏𝑠𝑒𝑣𝑎𝑡𝑖𝑜𝑛𝑠𝑖
 
The country measure of overall belonging to a specific cluster was possible by combining the 
measurement of high/low safety stock (relative positioning in the X axis) and high/low strategic 
stock (relative positioning in the Y axis). 
When comparing the cluster’s composition, it can be observed that most of the countries belong to 
the LL and LH clusters. This is consistent with the results presented in Table 14, where it can be 
                                                     
1 The industries considered in their study comprise: Manufacture of fabricated metal products; machinery and equipment; Manufacture of office, accounting, 
and computing machinery; Manufacture of electrical machinery and apparatus; Manufacture of radio, television, and communication equipment. 
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observed that the most populated clusters are the ones with low strategic stock (the population is 
around 86% for these two clusters combined). Only one country belongs to cluster HH: Finland.  
Cluster HL is integrated by Germany and the United States and, in the lower end, China and United 
Kingdom. The results stem from the fact that the Finland and United States affiliates’ have especial 
strategic stock policies.  
 
*The sizes of the circles indicate the number of observations per country in the sample 
Figure 14. Relative country positioning among clusters 
In the case of Finland, where Strategic Stock accounts for a median of 171 DOH, this is due to 
specific government regulations that requires the case study company to hold a specific amount of 
all products in its affiliate warehouse. The high levels of strategic and safety stock in the United 
States, Germany and the United Kingdom can be explained by the high sales volume in these 
countries, which make them key countries in driving the firm’s total revenues. A clear inventory 
driver can be identified from the analysis: Regulatory Constraints drive the strategic stock of the 
company. The present finding seems to be consistent with previous research conducted in the 
pharmaceutical industry (Shah, 2004; Uthayakumar and Priyan, 2013). 
6.2.3. The factors impacting inventory levels and configurations: a quantitative analysis 
The cluster configurations were then analysed in order to determine the most important factors 
driving total inventory levels in each configuration. In total, seven variables belonging to three of 
the categories in the IDM framework were selected from Table 12: Market Factors (Avg. Daily 
Demand), Internal Operation Capabilities (Order Size, Lead Time and Days On Hand), and Product 
Characteristics (U3U1Factor, Brand Name and Delivery System). Predictive modelling techniques 
were used to investigate which of the aforementioned variables had the highest impact on Total 
Stock Quantities in each cluster. The results are presented in Figure 15 and the findings summarized 
in Table 16 with the conclusions derived from the previous cluster analyses. The output of the 
statistical models and a summary of the results obtained can be found in Appendix C. 
 
Figure 15. Split of variable importance in impacting inventory levels per cluster (results from the DT model)  
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Table 16. Cluster Analysis: Factors impacting inventory levels (total stock) 
 
 
Cluster 1: HH 
High Strategic Stock 
High Safety Stock 
Cluster 1: HL 
High Strategic Stock 
Low Safety Stock 
Cluster 1: LH 
Low Strategic Stock 
High Safety Stock 
Cluster 1: LL 
Low Strategic Stock 
Low Safety Stock 
C
lu
s
te
r 
A
n
a
ly
s
is
 
Characteristics 
(across products and 
years) 
Median Strategic Stock: 15 
Median Safety Stock: 41 
Median Total Stock: 55 
Median Strategic Stock: 15 
Median Safety Stock: 30 
Median Total Stock: 43 
Median Strategic Stock: 0 
Median Safety Stock: 45 
Median Total Stock: 45 
Median Strategic Stock: 0 
Median Safety Stock: 30 
Median Total Stock: 30 
Countries belonging 
to the cluster 
Finland China, Czech Republic, Germany, 
United States and United Kingdom. 
Argentina, Australia, Bulgaria, 
Chile, Denmark, Hungary, Mexico, 
Netherlands, New Zealand, 
Switzerland, South Africa, South 
Korea, Russia, Taiwan, Thailand. 
Austria, Belgium, Canada, France, 
India, Italy, Latvia, Japan, Poland, 
Spain. 
Observations Finland is the only country with a 
specific policy on the amount of 
Strategic Stock that needs to be held 
at the affiliate (a median of 171 DOH). 
These countries are usually 
strategic, in terms of sales volume 
and have, therefore, strategic stock 
policies in place. 
These countries are usually 
located near to production sites, or 
have local production (packaging) 
facilities. 
N/A 
Stability of the 
cluster 
Not stable: Safety Stock and Total 
Stock have increased in the past 
three years 
Relatively stable over time: Safety 
Stock and Total Stock have 
decreased in the past three years 
Not stable: Safety Stock and Total 
Stock have increased in the past 
three years 
Stable over time 
Weight of variables 
impacting Total 
Stock (from the DT 
model) 
Days On Hand (53.4%), Average 
Daily Demand (22.8%), Order Size 
(14.3%), BrandName Grouped (4%), 
Lead Time Policy (2.5%), 
DeliverySystem (1.9%), U3U1Factor 
(1.1%). 
Days On Hand (36.6%), Average 
Daily Demand (27.5%), Order Size 
(21.7%), BrandName Grouped 
(4.7%), DeliverySystem (4.6%), 
U3U1Factor (3.9%), Lead Time 
Policy (1%). 
Average Daily Demand (36.6%), 
Days On Hand (19%), Order Size 
(14.5%), BrandName (13.1%), 
DeliverySystem (8.6%), 
U3U1Factor (6.3%), Lead Time 
Policy (1.9%). 
Average Daily Demand (22.6%), 
Days On Hand (19.1%), Order 
Size (14.3%), Lead Time Policy 
(18.1%), BrandNameGrouped 
(12.8%), DeliverySystem (9%), 
U3U1Factor (4.1%). 
 
Observations Highly dependent on Production 
factors (Days On Hand, Order Size) 
and Market Factors (Average Daily 
Demand); and less dependent on 
Product Characteristics (U3U1Factor 
and Brand Name, Delivery System), 
given its strategic positioning in the 
market.  
Highly dependent on Product 
Characteristics (Product 
complexity: U3U1Factor and Brand 
Name), given its strategic 
positioning in the market; but also 
on Market Factors (Avg. Daily 
Demand). 
Dependent on Market Factors 
(Avg. Daily Demand) and 
Production Factors (Days on Hand, 
Order Size), which trigger high 
levels of Safety Stock.  
The sample for the cluster is very 
big (24424 records), which makes 
it difficult to fit the model (low 
accuracy). 
Dependent on Market Factors and 
Production Factors. Less 
dependent on Product 
Characteristics (U3U1Factor or 
Brand Name).  
 Model Accuracy 
Adj. R-Squared (MLR) 
 
High: Adj. R-Squared 0.71 Medium: Adj. R-Squared 0.358  Very Low: Adj. R-Squared 0.032 Low: Adj. R-Squared 0.095 
 Model Accuracy 
x-val relative error 
(DT) 
High: x-val relative error  0.17  High: x-val relative error  0.19  Low: x-val relative error  0.55  Medium: x-val relative error 0.35 
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Overall, the results show that the most important variables driving inventory levels are DOH -
production throughput-, Order Size (both belong to the Production Capabilities category in the IDM 
framework) and Average Daily Demand, which belongs to the Market Factors category. Following 
in importance are the variable Brand Name and Lead Time, which represent the Product 
Characteristics and Internal Production Capabilities respectively. This result is constant in all 
clusters. Less important variables are the Delivery System and U3U1Factor (Product 
Characteristics). The results clearly show that high inventory levels are driven mainly by 
production-related factors. Market factors are second in importance, followed by product 
characteristics. This results contradict the survey analysis results, in which market factors received 
the highest scores. 
An interesting finding stemming from the results is that Total Stock Quantities in cluster HH are 
mostly driven by the production throughput (DOH). Furthermore, when comparing the variable 
across clusters, one can observe that the lower the stock levels, the less weight the production 
throughput has (compare clusters HH and LL). This confirms the findings obtained in the interviews 
conducted, in which interviewees suggested that high stock levels were driven by production sites 
pushing stock to the affiliates. Cluster LL, which represents low strategic and safety stock levels, 
has a more evenly distributed weight of factors, as it was expected; given that the cluster represents 
the “best” possible scenario. 
The variable Avg. Daily Demand, related to Market Factors, has relatively the same importance 
across clusters (between 22.8% and 27.5%). This results are also consistent with the survey 
answers, in which Average Demand was rated with high scores by most of the respondents.  
Finally, a higher significant relationship was expected between the variables Brand Name and 
Delivery System and high strategic stock levels. This variables were expected to have higher 
relative weights in the HH and HL clusters, given that strategic stock at affiliates in the case study 
company is set based on policies that depend on the sales value and the strategic importance of the 
product in each specific country. However, this relationship cannot be observed from the data.  
To conclude, it should be noted that no variables related to Financial Factors, Downstream Supply 
Chain Characteristics or Managerial and Cooperation factors from the IDM framework were 
included in the analysis. This is because, on the one hand, the case study company did not have this 
type of information stored in their ERP systems (for the Downstream Supply Chain Characteristics 
and Managerial and Cooperation factors) and, on the other hand, data on financial measures was not 
licensed by the company. Further research should be done to obtain quantitative data on these 
factors and investigate their impact on inventory levels. 
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This section presents the discussion of the qualitative and quantitative results obtained in this study, 
focusing on the applicability of the framework to the case firm. Subsequently, detailed insights on 
the 9 focus areas identified are provided and recommendations for improvement are suggested.  
The quantitative analysis identified four inventory configurations in the case study company, 
depending on the Strategic and Safety stock levels: HH, HL, LH and LL. Inventory configurations 
are relatively unstable over time, especially in clusters that present high safety stock levels (HH and 
LH). The number of stock-out items has reduced during the three-year time period, whereas the 
number of observations above the maximum stock level targets has a tendency to increase for all the 
clusters. Furthermore, there seems to be no correlation between having high safety stock and 
achieving higher service levels. The analysis also identified the most important factors behind each 
of the inventory configurations, being the demand and production throughput the main inventory 
drivers. Factors belonging to the Internal Operation Capabilities and Product Characteristics 
categories of the IDM framework are also important explanatory factors behind the company’s 
overall inventory levels. Regulatory requirements are key drivers behind inventory configurations 
with high strategic stock levels. 
The case study qualitative analysis is used to illustrate the practical applicability of the framework. 
The combination of the importance and impact scores has determined the stock positioning of the 
company with regards to inventory levels in comparison to the maximum overstock levels in two 
scenarios: the current situation of the company (AS-IS), and the optimal situation (TO-BE). The 
results have revealed that the company has a tendency of overstocking finished-goods in its 
affiliates’ warehouses (the AS-IS situation is at 57% of the maximum inventory levels attainable): 
      
 
 
This finding is supported by the survey results and interviews conducted, in which respondents 
recognized that the case study company does overstock finished-goods. This underpins the need of a 
qualitative assessment of the factors that can reduce the gap between the current and desired 
situation of the company and reduce the overall inventory levels to an optimal configuration. 
The significant gap between the AS-IS and TO-BE stocking positioning in the normalized scale is 
determined by 9 focus areas (represented by 9 factors of the IDM framework): Replenishment 
policies, Internal and Supplier Lead Times, Service Levels, Forecast Accuracy, Information 
Sharing, Production Strategy, Personal Bias, Production Capacity Utilization and 
Centralization/De-centralization. An explanation of the shortcoming identified is provided in Table 
17 and Table 18 and improvement suggestions are drawn for each of the factors. Applying the 
improvement suggestions could improve the company’s overstocking position by reducing their 
impact score to an optimal degree. 
The analysis of the focus areas suggests that if the case study company wishes to pursue a reduction 
of the inventories held at affiliates, increasing attention towards External factors and Downstream 
Supply Chain Capabilities should be placed. Closer collaboration between market access and supply 
chain functions; increased information sharing and transparency within the Product Supply 
organization and with external parties and developing KPIs to control the maximum stock amount 
to be held at affiliates should be the first steps to be taken. The focus of the company should be on 
forecasting, master planning and order promising, instead of production scheduling; and executive 
management should be involved in inventory management decisions by setting a clear strategy. 
Undertaking these actions would lead the organization towards a finished-goods inventory reduction 
setup rather than overstocking, especially in Safety Stock; thus closing the gap between the AS-IS 
and TO-BE scenarios. 
7. Discussion and improvement suggestions 
FOCUS AREAS 
AS-IS stock positioning 
57% 
TO-BE stock positioning 
24% 
Maximum inventory levels Minimum inventory levels 
0% overstock 100% overstock 
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Table 17. Focus areas: Indication of shortcomings in the case study company and suggestions for improvement  
Factor 
Replenishment policy- the IM 
model 
Internal Lead Times, Supplier 
and customer Lead Times 
High Service Levels: Stock-
out fear 
Forecast Accuracy 
Information Sharing- Stock 
Visibility 
Survey results  62.5% of respondents 
rated the ability of ERP 
systems to plan production 
and set inventory levels in 
accordance to what is 
needed with a score of 4 
or higher. 
 Planners rely more on the 
ERP’s ability to set the 
right safety stock levels 
than SC Managers. 
 Respondents rated Lead 
Times’ adherence to 
internal policies as 
medium-high. 
 Planners rated higher 
adherence to policies than 
SC Managers and 
Specialists. 
 87.6% of the respondents 
rated the number of stock-
outs to be low or very low 
(scores of 2 or lower). 
 1 outlier response rated 
the number of stock-outs 
of being very high.   
 No difference between the 
two groups of 
respondents. 
 Forecast was rated as not 
being accurate enough by 
88% of the survey 
respondents. 
 SC Managers and 
Specialists rated forecast 
accuracy with lower 
scores. 
 Stock visibility at affiliates 
was estimated to be good 
or very good in 50% of the 
cases and bad or very bad 
in the other 50%.  
 Scores were spread 
across the 5-point scale.  
 No difference between the 
two groups of 
respondents. 
Further 
investigation 
has 
concluded… 
 
 
 
 
 
 
 
 
The ERP systems implemented 
and IM model used are useful 
for planning stock in countries 
with stable demands. However, 
in smaller affiliates, demand is 
usually lumpy and therefore 
inventory is more difficult to 
predict. Besides, replenishment 
orders are set manually. 
The inventory management 
model (IM model) is deemed to 
be accurate enough; involving 
advanced simulation 
techniques. However, it is only 
used in MRP affiliates. 
Distortion derived from the units 
used in the model affect Safety 
Stock levels. 
Internal production lead time 
policies in the case study 
company are very long (42 
days on average), whereas the 
real production of a batch can 
be realized within significantly 
lower lead times.  The supplier 
side of lead times also presents 
inefficiencies: PPM provided by 
external supplier’s accounts for 
more than half of the total LT.  
Lead time variance at 
distributor’s networks adds 
uncertainty in the safety stock 
calculation (IM model), which 
leads to higher inventories. 
The findings reveal a tendency 
of every stakeholder in the 
company to add a safety factor 
to their lead times.  
There are very few stock-outs 
at the affiliates. Having high 
service levels to support 
forward customer projections of 
demand and meeting shelf life 
requirements are the focus at 
the sales affiliates. If demand 
predictions are not realized, this 
results in high inventories. 
The service level policy to the 
affiliates is currently at 99.5%, 
which is translated to having a 
maximum of 4 stock-outs per 
week. However, data shows 
that actual realized service 
level is 99.95% (2016), with 
approximately 10 stock-outs 
every 6 months. Safety stock 
increases exponentially with the 
increase of service levels. 
Although internal policies 
establish that forecast accuracy 
should be 80% in MRP 
countries and below 80% for 
non-MRP countries, the 
realized forecast accuracy is 
around 70% for MRP and lower 
in non-MRP. The forecasting 
frequency varies across 
affiliates (but is monthly in 
MRP). Poor demand forecasts 
based on distorted orders result 
in erratic capacity planning.  
The company avoids the stock-
out risks by increasing 
production schedules (and 
stock) and is working towards 
an increase in transparency of 
pharmacies and wholesalers’ 
buying behaviour. 
For MRP countries, physical 
stocks are maintained locally at 
the affiliates, with inventory 
planning and control 
centralised in HQ functions. 
Stock at non-MRP countries is 
not visible from HQ functions. 
Local Supply Chain Managers 
in these countries have 
visibility, but there are no ERP 
systems connected to 
central/HQ functions. Stock 
levels are inputted in files 
manually.  
Outbound transportation from 
affiliates to customers is 
outsourced to 3PLs, which also 
carry stock but do not always 
use VMI systems, which 
reduces stock visibility.  
Suggestions 
for 
improvement 
Better ERP systems could be 
allocated in non-MRP affiliates. 
Furthermore, the distortion on 
safety stock levels produced by 
the units/measures used (days 
on hand instead of quantity 
units) in the IM model should 
be explored in more detail. 
Providing more realistic lead 
time estimates would lead to 
reducing cumulative lead times. 
Closer collaboration with 
suppliers or a swift towards a 
more vertical-integrated supply 
chain would make inventory 
control easier; thus reducing 
inventory levels. 
Adhering to the strategically set 
service level policies towards 
the affiliates would imply a 
significant reduction on safety 
stock levels. 
 
Closer collaboration with the 
Market Access and Sales 
functions, increasing 
forecasting frequency and 
reviewing forecast at an 
aggregate level will potentially 
assist in successfully plotting 
demand fluctuations; reducing 
the need for safety stock.  
Increased information 
transparency across the 
delivery chain and the use of 
better-quality data and 
advanced information 
technologies (e.g., EDI) in 3PLs 
could help reduce the amount 
tied-up in inventories. 
*Shortcomings and improvement suggestions identified in the survey questionnaire 
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Table 18. Focus areas: Indication of shortcomings in the case study company and suggestions for improvement (cont.) 
Factor 
Production Strategy- Production mind-
set vs. needs at affiliates: Push vs. Pull 
Personal Bias. KPI-focused organization 
and  lack of management’s attention 
Production Capacity- More capacity 
installed than demand 
Centralization/De-
centralization 
Indication of 
Shortcomings 
from the 
interviews 
A MTS strategy is established for MRP 
affiliates and a MTO for non-MRP affiliates, 
but interviews have revealed an interesting 
factor: One of the measures of performance 
at production sites is the unit production 
cost, which is achieved by having the lines 
at full capacity, among other factors. 
Production planners often (advance orders) 
for MRP countries in order to be able to 
keep the lines running without stops. The 
mechanisms used by OP planners to 
advance orders consists on increasing the 
safety stock levels in the planning systems 
(called temporary safety stock). This 
temporary safety stock is then pushed to the 
affiliates, even though affiliates do not have 
that much demand for that specific period, 
leading to high inventory levels which might 
not be needed.  
Affiliates are measured on their ability to 
match the sales targets (and therefore, on 
ensuring high service levels). There are no 
KPIs in place to measure the amount of 
overstock held at affiliates. Affiliates only 
ask planners to stop pushing orders when 
they reach their maximum space capacity in 
their warehouses.  
KPIs are employed to keep track on the 
operational performance of different 
processes and parts of the case study 
company. While KPI measurement ensures 
high performance in some areas, it can also 
lead to generate distortion and non-desired 
behaviours in other parts of the organization, 
such as the “unit production cost KPI”. 
Interviewees regarded the company as 
being a very supply-driven organization. The 
KPIs in place are oriented towards being 
able to meet demand and being able to 
supply, but there are no KPIs measuring the 
amount of overstock held at affiliates; 
leading production sites to push their 
production to the affiliates with capacity in 
their warehouses. 
There are is a lack of involvement from 
executive management in inventory planning 
decisions, which is reflected in the KPIs 
established within the organization. 
 
In the current situation production sites are 
not at full capacity utilization throughout 
the year. One of the reasons is that the 
case study company has more capacity 
installed than demand, given two main 
reasons:  
(i) Capacity and improvement expansions 
made on existing facilities to override the 
out-phased ones (mainly due to regulatory 
constraints), and 
(ii) Demand growth predictions made in 
previous years not having realised. 
The upgrades made in production facilities 
have increased the capacity of the lines 
significantly in the past recent years. If this 
fact is added to a lower-than-expected 
increase in sales volumes, the result is that 
manufacturing capacity insufficiently 
flexible to mirror actual demand, and 
products are manufactured at a steady 
rate, resulting in high inventory levels. 
The production agreements are prepared 
once a year and then revised with updated 
demand forecast information halfway 
throughout the year. 
The inventory planning and 
control functions are centralized 
in the HQ with the use of ERP 
systems in MRP affiliates, but the 
physical inventory is de-
centralised locally at the 
affiliates.  
For non-MRP countries, both the 
planning functions and physical 
inventories are de-centralised 
locally. 
 
Physical centralization is only 
achieved in the shipping hub in 
DK, which is used as a buffer 
and as a stocking point. 
However, no other stocking 
points exist between the shipping 
hub and the affiliates. 
 
 
 
 
 
 
 
Quotes “Even though we have the right tools in 
place, the production agreements are on top 
of the agenda”. “All planners increase safety 
stocks to be able to cover fluctuations, but 
do we really need it?” 
“We are a production-driven organization”. 
”Do we have the right KPIs in place, in order 
to have the right amount of inventories?”  
“We are driven by the production agreement 
KPI, unit cost and the Stock below 50 KPI.”  
“I would challenge the forecast we made 
five years ago”.  
“We have a rather de-centralised 
setup, with stock scattered 
across regions. But we are taking 
measures to address the 
situation”. 
Suggestions 
for 
improvement 
Interviewees suggest that a cultural change 
in mind-set towards the needs at affiliates 
and a make-to-order production strategy 
would lead to lower inventory levels. The 
focus should be on forecasting, master 
planning and order promising, instead of 
production scheduling. 
Suggestions from the interviewees to revert 
this situation include developing new KPIs 
controlling the amount of stock tied up at 
affiliates, instead of just measuring the 
amount of stock over the maximum target at 
a production site level. Executive 
management should be involved in inventory 
management decisions. 
Allowing production sites to revisit their 
production agreements more often could 
lead to less behavioural-driven situations, 
such as raising safety stock levels to 
comply with the agreements. Addressing 
capacity issues would lead the 
organization towards reducing inventories. 
Consolidating the inventory 
structure of the global company 
into fewer central warehouses, 
instead of keeping stock at each 
affiliate, would reduce the 
amount tied up in inventories. 
*Shortcomings and improvement suggestions identified in the interviews 
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This section covers the theoretical novelty value of the present study (contribution to theory) and 
the relevance of the developed framework to practitioners, thus exploring the contribution to 
practice. 
8.1. Contribution to theory 
Traditionally, inventory management research has focused on studying the impact of tangible, 
quantitative factors on a company’s inventory levels. More abstract parameters such as managerial 
and cooperation factors are often ignored when assessing the company’s optimal inventory levels. 
Furthermore, the vast majority of existent literature does not examine the particular inventory 
archetypes that companies adopt within a single case study company but rather performs 
comparisons across companies.  
This paper contributes to the body of literature by taking a more holistic approach to the subject in 
determining key inventory drivers and including a situation assessment of the company used as a 
case study. Therefore, the main theoretical contributions of this paper are: 
 The identification of key factors and their influence on finished goods inventory levels in the 
pharmaceutical industry. 
 The development of a theoretical framework. The bi-dimensional structure of the framework, 
illustrated by its double axis (Internal vs. External and Upstream vs. Downstream SC 
Characteristics, covers the full supply chain spectrum at several abstraction levels, which is an 
improvement to the model in which the framework was inspired. 
 A qualitative procedure for validating and refining the developed framework, which can help 
identifying the key focus areas where efforts should be placed to pursue inventory 
optimization initiatives. 
 A quantitative procedure for examining a firm’s inventory configurations and the drivers 
behind these configurations. The use of statistical methods in a single case study company 
also represents a methodological novelty. 
8.2.   Contribution to practice  
This paper provides practitioners with a concrete framework to assess what are the most important 
factors impacting inventory levels within a specific pharmaceutical supply chain configuration, 
determining the positioning of the company with regards to its inventory levels in comparison to the 
maximum overstock levels. The framework allows supply chain managers to reflect on potential 
factors which might not have been considered before in any of the processes established within the 
firm, further identifying key areas in which efforts can be placed in order to pursue inventory 
reduction initiatives. 
To utilize the IDM framework, a process of 10 sequential steps is proposed. The framework’s 
application procedure is illustrated in Figure 16. 
Step 1: Evaluate the current inventory configurations of the company and review the IDM 
framework to identify potential additional factors to be considered in the firm’s specific supply 
chain configuration. 
Step 2: Score each of the factors in the IDM framework (and any additional factors identified) from 
1-5 in order to determine the importance score. This step can be done by means of a survey 
questionnaire or conducting a workshop with relevant stakeholders within the firm to align on the 
scores. 
Step 3: Determine the impact score for each of the factors in the current supply chain setup of the 
firm (AS-IS assessment); assigning the following values: (1) if the factor points towards high 
inventory levels, (0) if neutral impact or ambiguous and (-1) if the factor points towards low 
inventory levels. 
8. Implications on theory and practice  
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Step 4: Determine the impact score for each of the factors in the TO-BE situation; identifying the 
factors whose impact score could be lowered from (1) to (0). 
Steps 4 and 5 should be the result of a workshop conducted with several supply chain managers; or 
alternatively, the result of an assessment made after conducting interviews with relevant 
stakeholders. 
Step 5: Multiply the importance and impact score to obtain the Total Score (both in the AS-IS and 
TO-BE situations). Compare with the Potential Score in order to determine positioning of the 
company with regards to inventory levels in comparison to the maximum overstock levels. 
Steps 6 and 7: Can be executed simultaneously. Identify potential improvement areas (focus areas) 
and determine improvement suggestions and further actions for each of the areas.  
Step 8: Develop business cases to evaluate the suggestions for improvement and actions proposed in 
the previous step.  
Step 9: Decide on the actions to be implemented and execute the actions. 
Step 10: Re-evaluate the desired inventory levels each time there is a significant change in the 
supply chain environment.  
Only steps 1-7 have been covered in this paper. PharmaNordic is currently evaluating three 
improvement suggestions and moving towards steps 8-10 to determine concrete inventory 
optimization initiatives.  
1 
Review the list of proposed factors in the IDM 
framework to identify potential additional factors 
specific to the supply chain configuration of the firm 
Determine the importance score for 
each factor: Score each of the factors 
on a scale from 1-5 
Determine the impact score for each 
factor in the AS-IS situation. 
Determine the impact score for each factor in 
the TO-BE situation. 
Identify the focus areas (the ones 
determining the gap between the AS-
IS situation and the TO-BE situation) 
Determine improvement 
suggestions 
Evaluate improvement 
suggestions developing 
business cases 
Implement feasible 
solutions 
Review implemented 
solutions 
Multiply the importance and impact score to obtain the 
Total Score (both in the AS-IS and TO-BE situations). 
Compare with the Potential Score in order to determine 
positioning of the company with regards to inventory levels 
in comparison to a maximum attainable level. 
Inventory reduction 
strategies review 
2 
3 
4 
5 6 
7 
8 
9 
10 
Figure 16. Suggested IDM framework application procedure 
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In recent years, inventory reduction has been a key objective of pharmaceutical companies, 
especially within cost optimization initiatives. However, a one-way strategy towards zero-inventory 
is in reality inapplicable, due to the strategic nature and importance of the products being 
commercialised. Finished-goods inventory in the pharmaceutical industry is closely related to the 
manufacturing systems and the supply chain configurations that companies adopt. In fact, there is a 
complex relationship between the inventory configurations that a company adopts and the factors 
behind them.  
Traditionally, inventory management research has focused on studying the impact of tangible, 
quantitative factors on the inventory levels of a company. More abstract parameters are often not 
addressed when assessing the company’s optimal inventory levels. Furthermore, the vast majority 
of existent literature does not examine the particular inventory archetypes within a single case study 
company but performs comparisons across companies.  
The pharmaceutical industry is, therefore, lacking of a more holistic and practical approach to the 
subject of finding the optimal inventory levels. This paper contributes to the body of literature with 
novel insights by extensively examining inventory drivers and their impact on finished goods 
inventory levels in the pharmaceutical industry, proposing a theoretical framework which is useful 
for practitioners and relevant to the academia. Furthermore, the applicability of the framework to a 
case study company, which includes a situation assessment of the company’s stocking positioning, 
provides relevant insights into inventory reduction initiatives.  
The findings in this study suggest that while external and downstream supply chain factors are 
recognized as being critical to pursue inventory optimization initiatives, the case study company is 
oriented towards a production and supply setup, being internal factors the ones prevailing when 
making inventory management decisions. The findings furthermore suggest that this production-
oriented setup is the cause of the overstocking of products in the company’s affiliates. 
Furthermore, this study shows that inventory configurations are relatively unstable over time, 
especially in clusters which present high safety stock levels, and that production features and 
product characteristics are important explanatory factors behind high inventory levels. Regulatory 
requirements also explain the high strategic inventory levels that companies hold in particular 
countries. Despite its current overstocking situation, the company is not able to achieve 100% 
service levels. This fact underpins the need for applying the inventory reduction initiatives 
suggested in this study. 
9.1. Limitations and notes for further research 
This paper is not without limitations. The main limitation of the developed framework is that the 
factors considered present different abstraction levels. Further steps in refining the model could be 
done in order to separate the factors in different abstraction levels. This improvement would 
facilitate the framework’s application. 
Another limitation of the framework is the need for more generalized industry data. The descriptive 
approach pursued using a single case study company in order to validate the framwork has its 
limitations if the results are to be generalized and extended to other companies in the industry.   
Further research should comprise extending the analysis and pursue a multiple-case study approach. 
Several survey studies should be conducted within different pharmaceutical companies in order to 
be able to benchmark the results and compare each factor’s importance and impact scores among 
different companies. This way new inventory drivers could be identified and a more robust 
framework would be obtained. 
9. Conclusions 
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